mp:VDraft3.0.0 testgegevens voorschrift addendum: verschil tussen versies
| (15 tussenliggende versies door 4 gebruikers niet weergegeven) | |||
| Regel 12: | Regel 12: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1*|| Maak screenshot(s) waarop zichtbaar is dat gebruiksperiode kan worden ingevoerd|| <div | + | |1.1*|| Maak screenshot(s) waarop zichtbaar is dat gebruiksperiode kan worden ingevoerd|| <div>Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind|| MBH_300_start_eind_MA|| MBH_300_start_eind_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_300_start_duur|| MBH_300_start_duur_MA|| MBH_300_start_duur_VV | |1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_300_start_duur|| MBH_300_start_duur_MA|| MBH_300_start_duur_VV | ||
| Regel 23: | Regel 23: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.5|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_300_dosis_stuks|| MBH_300_dosis_stuks_MA|| MBH_300_dosis_stuks_VV | |1.5|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_300_dosis_stuks|| MBH_300_dosis_stuks_MA|| MBH_300_dosis_stuks_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |1.6|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met onzekerheidscriterium</span></div>|| MBH_300_start_criterium|| MBH_300_start_criterium_MA|| MBH_300_start_criterium_VV | ||
|} | |} | ||
<section end=overview-VOS-1 /> | <section end=overview-VOS-1 /> | ||
| Regel 87: | Regel 89: | ||
|4.1a|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV | |4.1a|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.1b|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (persistent)</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| | + | |4.1b|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (persistent)</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.2a|| Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met test op labuitwisseling</span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met NHG codes</span></div>|| | + | |4.2a|| Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met test op labuitwisseling</span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met NHG codes</span></div>|| MBH_300_VOS_Lab|| MBH_300_VOS_Lab_MA|| MBH_300_VOS_Lab_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.2b|| Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Medicatievoorschrift, met test op labuitwisseling </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met LOINC codes</span></div>|| | + | |4.2b|| Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Medicatievoorschrift, met test op labuitwisseling </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met LOINC codes</span></div>|| MBH_300_VOS_Lab|| MBH_300_VOS_Lab_MA|| MBH_300_VOS_Lab_VV |
|} | |} | ||
<section end=overview-VOS-4 /> | <section end=overview-VOS-4 /> | ||
| Regel 133: | Regel 135: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|6.16|| Deze test is optioneel en alleen bedoeld voor de trombosedienstsystemen.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_300_WDS_trombose_medicatie|| MBH_300_WDS_trombose_medicatie_MA|| MBH_300_WDS_trombose_medicatie_VV | |6.16|| Deze test is optioneel en alleen bedoeld voor de trombosedienstsystemen.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_300_WDS_trombose_medicatie|| MBH_300_WDS_trombose_medicatie_MA|| MBH_300_WDS_trombose_medicatie_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |6.17|| Maak screenshot(s) waarop zichtbaar is dat de frequentie i.c.m. toedientijden ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Redundante frequentie</span></div>|| MBH_300_redundantefrequentie|| MBH_300_redundantefrequentie_MA|| MBH_300_redundantefrequentie_VV | ||
|} | |} | ||
<section end=overview-VOS-6 /> | <section end=overview-VOS-6 /> | ||
| Regel 141: | Regel 145: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_300_magistraalalleingredienten | + | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MA|| MBH_300_magistraalalleingredienten_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MA|| MBH_300_magistraalactieveingredient_VV | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MA|| MBH_300_magistraalactieveingredient_VV | ||
| Regel 150: | Regel 154: | ||
|} | |} | ||
<section end=overview-VOS-7 /> | <section end=overview-VOS-7 /> | ||
| + | === Scenarioset 8=== | ||
| + | <section begin=overview-VOS-8 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.1|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Verstrekkingsverzoek onder andermans medicatieafspraak</div>|| MBH_300_VVandermansMA|| MBH_300_VVandermansMA_MA|| MBH_300_VVandermansMA_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.2|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Stoppen andermans medicatieafspraak</div>|| MBH_300_stakenandermansMA|| MBH_300_stakenandermansMA_MA2|| | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.3|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Onderbreken andermans medicatieafspraak</div>|| MBH_300_stakenandermansMA|| MBH_300_stakenandermansMA_MA2|| | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.4|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Wijzigen andermans medicatieafspraak</div>|| MBH_300_wijzigenandermansMA|| MBH_300_wijzigenandermansMA_MA_techstaken<br>MBH_300_wijzigenandermansMA_MA2|| | ||
| + | |} | ||
| + | <section end=overview-VOS-8 /> | ||
=== Scenarioset 9=== | === Scenarioset 9=== | ||
<section begin=overview-VOS-9 /> | <section begin=overview-VOS-9 /> | ||
| Regel 168: | Regel 187: | ||
|9.4|| Maak screenshot(s) waarop zichtbaar is dat een financiële indicatiecode ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Financiële indicatiecode</span></div>|| MBH_300_financiele_indicatiecode|| MBH_300_financiele_indicatiecode_MA|| MBH_300_financiele_indicatiecode_VV | |9.4|| Maak screenshot(s) waarop zichtbaar is dat een financiële indicatiecode ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Financiële indicatiecode</span></div>|| MBH_300_financiele_indicatiecode|| MBH_300_financiele_indicatiecode_MA|| MBH_300_financiele_indicatiecode_VV | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9. | + | |9.5a|| Maak screenshot(s) waarop zichtbaar is dat een geannuleerd indicator ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Geannuleerd indicator</span></div>|| MBH_300_geannuleerd_indicator|| MBH_300_geannuleerd_indicator_MA|| MBH_300_geannuleerd_indicator_VV |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.5b|| Maak screenshot(s) waarop zichtbaar is dat een geannuleerd indicator ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Geannuleerd indicator</span></div>|| MBH_300_geannuleerd_indicator|| MBH_300_geannuleerd_indicator_MA|| MBH_300_geannuleerd_indicator_VV | ||
|} | |} | ||
<section end=overview-VOS-9 /> | <section end=overview-VOS-9 /> | ||
| Regel 208: | Regel 229: | ||
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1|| <div | + | |1.1|| <div>Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind|| MBH_300_start_eind_MA|| MBH_300_start_eind_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_300_start_duur|| MBH_300_start_duur_MA|| MBH_300_start_duur_VV | |1.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_300_start_duur|| MBH_300_start_duur_MA|| MBH_300_start_duur_VV | ||
| Regel 219: | Regel 240: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_300_dosis_stuks|| MBH_300_dosis_stuks_MA|| MBH_300_dosis_stuks_VV | |1.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_300_dosis_stuks|| MBH_300_dosis_stuks_MA|| MBH_300_dosis_stuks_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |1.6|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met onzekerheidscriterium</span></div>|| MBH_300_start_criterium|| MBH_300_start_criterium_MA|| MBH_300_start_criterium_VV | ||
|} | |} | ||
<section end=overview-VOO-1 /> | <section end=overview-VOO-1 /> | ||
| Regel 283: | Regel 306: | ||
|4.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV | |4.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (persistent)</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| | + | |4.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht (persistent)</span></div>|| MBH_300_VOS_Lengte_Gewicht|| MBH_300_VOS_Lengte_Gewicht_MA|| MBH_300_VOS_Lengte_Gewicht_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met test op labuitwisseling</span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met NHG codes</span></div>|| | + | |4.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met test op labuitwisseling</span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met NHG codes</span></div>|| MBH_300_VOS_Lab|| MBH_300_VOS_Lab_MA|| MBH_300_VOS_Lab_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |4.2b|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Medicatievoorschrift, met test op labuitwisseling </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met LOINC codes</span></div>|| | + | |4.2b|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Medicatievoorschrift, met test op labuitwisseling </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;"> </span><span style="background-color: #f9f9f9; color: #222222; font-family: sans-serif; font-size: 14px;">met LOINC codes</span></div>|| MBH_300_VOS_Lab|| MBH_300_VOS_Lab_MA|| MBH_300_VOS_Lab_VV |
|} | |} | ||
<section end=overview-VOO-4 /> | <section end=overview-VOO-4 /> | ||
| Regel 329: | Regel 352: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|6.16|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_300_WDS_trombose_medicatie|| MBH_300_WDS_trombose_medicatie_MA|| MBH_300_WDS_trombose_medicatie_VV | |6.16|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_300_WDS_trombose_medicatie|| MBH_300_WDS_trombose_medicatie_MA|| MBH_300_WDS_trombose_medicatie_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |6.17|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Redundante frequentie</span></div>|| MBH_300_redundantefrequentie|| MBH_300_redundantefrequentie_MA|| MBH_300_redundantefrequentie_VV | ||
|} | |} | ||
<section end=overview-VOO-6 /> | <section end=overview-VOO-6 /> | ||
| Regel 337: | Regel 362: | ||
| Scenario|| Beschrijving|| MBH id|| MA id|| VV id | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_300_magistraalalleingredienten | + | |7.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MA|| MBH_300_magistraalalleingredienten_VV |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MA|| MBH_300_magistraalactieveingredient_VV | |7.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MA|| MBH_300_magistraalactieveingredient_VV | ||
| Regel 346: | Regel 371: | ||
|} | |} | ||
<section end=overview-VOO-7 /> | <section end=overview-VOO-7 /> | ||
| + | === Scenarioset 8=== | ||
| + | <section begin=overview-VOO-8 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.1|| <div>Verstrekkingsverzoek onder andermans medicatieafspraak</div>|| MBH_300_VVandermansMA|| MBH_300_VVandermansMA_MA|| MBH_300_VVandermansMA_VV | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.2|| <div>Stoppen andermans medicatieafspraak</div>|| MBH_300_stakenandermansMA|| MBH_300_stakenandermansMA_MA2|| | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.3|| <div>Onderbreken andermans medicatieafspraak</div>|| MBH_300_stakenandermansMA|| MBH_300_stakenandermansMA_MA2|| | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.4|| <div>Wijzigen andermans medicatieafspraak</div>|| MBH_300_wijzigenandermansMA|| MBH_300_wijzigenandermansMA_MA_techstaken<br>MBH_300_wijzigenandermansMA_MA2|| | ||
| + | |} | ||
| + | <section end=overview-VOO-8 /> | ||
=== Scenarioset 9=== | === Scenarioset 9=== | ||
<section begin=overview-VOO-9 /> | <section begin=overview-VOO-9 /> | ||
| Regel 364: | Regel 404: | ||
|9.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Financiële indicatiecode</span></div>|| MBH_300_financiele_indicatiecode|| MBH_300_financiele_indicatiecode_MA|| MBH_300_financiele_indicatiecode_VV | |9.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Financiële indicatiecode</span></div>|| MBH_300_financiele_indicatiecode|| MBH_300_financiele_indicatiecode_MA|| MBH_300_financiele_indicatiecode_VV | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9. | + | |9.5a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Geannuleerd indicator</span></div>|| MBH_300_geannuleerd_indicator|| MBH_300_geannuleerd_indicator_MA|| MBH_300_geannuleerd_indicator_VV |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.5b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Geannuleerd indicator</span></div>|| MBH_300_geannuleerd_indicator|| MBH_300_geannuleerd_indicator_MA|| MBH_300_geannuleerd_indicator_VV | ||
|} | |} | ||
<section end=overview-VOO-9 /> | <section end=overview-VOO-9 /> | ||
| Regel 443: | Regel 485: | ||
|style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:20 uur | |style="background-color: white;"|T om 11:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 496: | Regel 538: | ||
|style="background-color: white;"|MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:20 uur | |style="background-color: white;"|T om 11:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 506: | Regel 548: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|5 stuks | |style="background-color: white;"|5 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 515: | Regel 557: | ||
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 522: | Regel 564: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_start_eind_MA | + | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 540: | Regel 582: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 560: | Regel 602: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 574: | Regel 616: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 587: | Regel 629: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 643: | Regel 685: | ||
|style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:30 uur | |style="background-color: white;"|T om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 696: | Regel 738: | ||
|style="background-color: white;"|MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:30 uur | |style="background-color: white;"|T om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 706: | Regel 748: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 718: | Regel 760: | ||
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 725: | Regel 767: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_start_duur_MA | + | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 743: | Regel 785: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 763: | Regel 805: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 777: | Regel 819: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 790: | Regel 832: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 846: | Regel 888: | ||
|style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:30 uur | |style="background-color: white;"|T om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 899: | Regel 941: | ||
|style="background-color: white;"|MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:30 uur | |style="background-color: white;"|T om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 909: | Regel 951: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|28 stuks | |style="background-color: white;"|28 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 918: | Regel 960: | ||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 925: | Regel 967: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_start_duur2_MA | + | |style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 943: | Regel 985: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 963: | Regel 1.005: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 977: | Regel 1.019: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 990: | Regel 1.032: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.046: | Regel 1.088: | ||
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:32 uur | |style="background-color: white;"|T om 11:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.096: | Regel 1.138: | ||
|style="background-color: white;"|MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:32 uur | |style="background-color: white;"|T om 11:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.106: | Regel 1.148: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.115: | Regel 1.157: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.122: | Regel 1.164: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_chronisch_MA | + | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 1.140: | Regel 1.182: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 1.160: | Regel 1.202: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.174: | Regel 1.216: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.187: | Regel 1.229: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.243: | Regel 1.285: | ||
|style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 11:32 uur | |style="background-color: white;"|T - 20 dagen om 11:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.293: | Regel 1.335: | ||
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:35 uur | |style="background-color: white;"|T om 11:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.303: | Regel 1.345: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.312: | Regel 1.354: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.319: | Regel 1.361: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_chronisch_MA | + | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 1.337: | Regel 1.379: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 1.357: | Regel 1.399: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.371: | Regel 1.413: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.384: | Regel 1.426: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.440: | Regel 1.482: | ||
|style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 11:35 uur | |style="background-color: white;"|T om 11:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.493: | Regel 1.535: | ||
|style="background-color: white;"|MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 11:35 uur | |style="background-color: white;"|T om 11:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.503: | Regel 1.545: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|1 stuk | |style="background-color: white;"|1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.512: | Regel 1.554: | ||
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.519: | Regel 1.561: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_dosis_stuks_MA | + | |style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 1.537: | Regel 1.579: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 1.557: | Regel 1.599: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.571: | Regel 1.613: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.584: | Regel 1.626: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.593: | Regel 1.635: | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mv-mp-vo-tst-1-5-eenheid-dosis-stuks-v30 /><section end=mv-mp-vo-tst-1-5-eenheid-dosis-stuks-v30 /> | |}<section end=mbhs-mv-mp-vo-tst-1-5-eenheid-dosis-stuks-v30 /><section end=mv-mp-vo-tst-1-5-eenheid-dosis-stuks-v30 /> | ||
| − | == TEST Scenarioset | + | == TEST Scenarioset 1 MA met onzekerheidscriterium== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /><section begin=patient-mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.617: | Regel 1.659: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /><section begin=mbhs-mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /> |
| − | ==== Scenario | + | ==== Scenario 1.6 - MBH_300_start_criterium==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_start_criterium_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.638: | Regel 1.680: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten)'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 1.659: | Regel 1.701: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_start_criterium_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.694: | Regel 1.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 1.704: | Regel 1.743: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.722: | Regel 1.761: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.736: | Regel 1.775: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 1.758: | Regel 1.797: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Telefoonnummer | |colspan="2"|Telefoonnummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1645645000 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.774: | Regel 1.813: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.787: | Regel 1.826: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /><section end=mv-mp-vo-tst-1-6-ingangsdatum-criterium-v30 /> |
| − | == TEST Scenarioset 2 | + | == TEST Scenarioset 2 Aanvullende Instructie== |
| − | <section begin=mv-mp-vo-tst-2- | + | <section begin=mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /><section begin=patient-mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.830: | Regel 1.869: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-2- | + | |}<section end=patient-mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /><section begin=mbhs-mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.1 - MBH_300_aanvullendeinstructie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_aanvullendeinstructie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.841: | Regel 1.880: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 12 maanden | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 1.862: | Regel 1.904: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | + | |style="background-color: white;"|1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Bij het eten innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_aanvullendeinstructie_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.894: | Regel 1.936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 1.906: | Regel 1.948: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|180 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.922: | Regel 1.964: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.943: | Regel 1.982: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 1.963: | Regel 2.002: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.977: | Regel 2.016: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.990: | Regel 2.029: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-2- | + | |}<section end=mbhs-mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /><section end=mv-mp-vo-tst-2-1-aanvullendeinstructie-v30 /> |
| − | == TEST Scenarioset 2 | + | == TEST Scenarioset 2 Toelichting== |
| − | <section begin=mv-mp-vo-tst-2- | + | <section begin=mv-mp-vo-tst-2-2-toelichting-v30 /><section begin=patient-mv-mp-vo-tst-2-2-toelichting-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.033: | Regel 2.072: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-2- | + | |}<section end=patient-mv-mp-vo-tst-2-2-toelichting-v30 /><section begin=mbhs-mv-mp-vo-tst-2-2-toelichting-v30 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.2 - MBH_300_toelichting==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_toelichting_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.044: | Regel 2.083: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 2.066: | Regel 2.102: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.081: | Regel 2.114: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 2.087: | Regel 2.120: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toelichting | ||
| + | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_toelichting_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.100: | Regel 2.136: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 2.112: | Regel 2.148: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.128: | Regel 2.164: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toelichting |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.146: | Regel 2.185: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 2.166: | Regel 2.205: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.180: | Regel 2.219: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.193: | Regel 2.232: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-2- | + | |}<section end=mbhs-mv-mp-vo-tst-2-2-toelichting-v30 /><section end=mv-mp-vo-tst-2-2-toelichting-v30 /> |
| − | == TEST Scenarioset 2 | + | == TEST Scenarioset 2 Reden van voorschrijven== |
| − | <section begin=mv-mp-vo-tst-2- | + | <section begin=mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /><section begin=patient-mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.236: | Regel 2.275: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-2- | + | |}<section end=patient-mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /><section begin=mbhs-mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.3 - MBH_300_redenvanvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_redenvanvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.247: | Regel 2.286: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.261: | Regel 2.300: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 27 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 2.269: | Regel 2.308: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenVanVoorschrijven | ||
| + | |style="background-color: white;"|Reumatoide artritis (code = 'L88.01' in codeSystem 'ICPC-1'): Reumatoide artritis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.281: | Regel 2.323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 2.287: | Regel 2.329: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_redenvanvoorschrijven_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.303: | Regel 2.342: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 2.315: | Regel 2.354: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|20 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.331: | Regel 2.370: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.352: | Regel 2.388: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 2.372: | Regel 2.408: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.386: | Regel 2.422: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.399: | Regel 2.435: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-2- | + | |}<section end=mbhs-mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /><section end=mv-mp-vo-tst-2-3-redenvanvoorschrijven-v30 /> |
| − | == TEST Scenarioset 2 | + | == TEST Scenarioset 2 Aanvullende informatie en wensen== |
| − | <section begin=mv-mp-vo-tst-2- | + | <section begin=mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /><section begin=patient-mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.442: | Regel 2.478: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-2- | + | |}<section end=patient-mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /><section begin=mbhs-mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.4 - MBH_300_aanvullendeinformatiewensen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_aanvullendeinformatiewensen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.453: | Regel 2.489: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.467: | Regel 2.503: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 2.477: | Regel 2.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInformatie |
| − | |style="background-color: white;"|Bewust | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_aanvullendeinformatiewensen_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.512: | Regel 2.545: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 2.524: | Regel 2.557: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.540: | Regel 2.573: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeWensen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.558: | Regel 2.594: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 2.578: | Regel 2.614: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.592: | Regel 2.628: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.605: | Regel 2.641: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-2- | + | |}<section end=mbhs-mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /><section end=mv-mp-vo-tst-2-4-aanvullendeinformatiewensen-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 2 Toedieningsweg== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-2-5-toedieningsweg-v30 /><section begin=patient-mv-mp-vo-tst-2-5-toedieningsweg-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.625: | Regel 2.661: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 2.635: | Regel 2.671: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan | + | |rowspan="2"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-2-5-toedieningsweg-v30 /><section begin=mbhs-mv-mp-vo-tst-2-5-toedieningsweg-v30 /> |
| − | ==== Scenario | + | ==== Scenario 2.5 - MBH_300_Toedieningsweg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_Toedieningsweg_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.662: | Regel 2.695: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.676: | Regel 2.709: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 2.686: | Regel 2.719: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanvullendeInformatie | ||
| + | |style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_Toedieningsweg_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.715: | Regel 2.754: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 2.727: | Regel 2.766: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.743: | Regel 2.782: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.761: | Regel 2.800: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 2.781: | Regel 2.820: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.795: | Regel 2.834: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.808: | Regel 2.847: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-2-5-toedieningsweg-v30 /><section end=mv-mp-vo-tst-2-5-toedieningsweg-v30 /> |
| − | == TEST Scenarioset 3 Stoppen== | + | == TEST Scenarioset 3 (initieren scenario) Stoppen== |
| − | <section begin=mv-mp-vo-tst-3- | + | <section begin=mv-mp-vo-tst-3-1a-stoppen-v30 /><section begin=patient-mv-mp-vo-tst-3-1a-stoppen-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.830: | Regel 2.869: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 2.841: | Regel 2.880: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-1a-stoppen-v30 /><section begin=mbhs-mv-mp-vo-tst-3-1a-stoppen-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.1a - MBH_300_stoppen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_stoppen_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.865: | Regel 2.904: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 280 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 2.879: | Regel 2.918: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 280 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 2.890: | Regel 2.926: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.912: | Regel 2.945: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_stoppen_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|180 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
|style="background-color: white;"|MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.935: | Regel 3.003: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 2.955: | Regel 3.023: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.969: | Regel 3.037: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 3 | + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
| − | <section begin=mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-3-1a-stoppen-v30 /><section end=mv-mp-vo-tst-3-1a-stoppen-v30 /> | ||
| + | == TEST Scenarioset 3 Stoppen== | ||
| + | <section begin=mv-mp-vo-tst-3-1b-stoppen-v30 /><section begin=patient-mv-mp-vo-tst-3-1b-stoppen-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.991: | Regel 3.072: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 3.002: | Regel 3.083: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-1b-stoppen-v30 /><section begin=mbhs-mv-mp-vo-tst-3-1b-stoppen-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.1b - MBH_300_stoppen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_stoppen_MA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.026: | Regel 3.107: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 18:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 1 dag | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 3.045: | Regel 3.132: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.064: | Regel 3.154: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.122: | Regel 3.177: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 3.142: | Regel 3.197: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.156: | Regel 3.211: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | + | |}<section end=mbhs-mv-mp-vo-tst-3-1b-stoppen-v30 /><section end=mv-mp-vo-tst-3-1b-stoppen-v30 /> | |
| − | + | == TEST Scenarioset 3 (initieren scenario) Wijzigen MA (verhoging)== | |
| − | + | <section begin=mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /><section begin=patient-mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | ||
| − | == TEST Scenarioset 3 Wijzigen (verhoging)== | ||
| − | <section begin=mv-mp-vo-tst-3- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 3.191: | Regel 3.233: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 3.202: | Regel 3.244: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /><section begin=mbhs-mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.2a - MBH_300_wijzigen_verhoging==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verhoging_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.226: | Regel 3.268: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 08:02 uur | |style="background-color: white;"|T om 08:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.245: | Regel 3.287: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.260: | Regel 3.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.266: | Regel 3.305: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 3.279: | Regel 3.311: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_wijzigen_verhoging_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.286: | Regel 3.318: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 08:02 uur | |style="background-color: white;"|T om 08:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Auteur | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.311: | Regel 3.329: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.318: | Regel 3.339: | ||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 3.395: | Regel 3.364: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 3.415: | Regel 3.384: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.429: | Regel 3.398: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.442: | Regel 3.411: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |}<section end=mbhs-mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /><section end=mv-mp-vo-tst-3-2a-wijzigen-verhoging-v30 /> |
| − | == TEST Scenarioset 3 | + | == TEST Scenarioset 3 Wijzigen (verhoging)== |
| − | <section begin=mv-mp-vo-tst-3- | + | <section begin=mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /><section begin=patient-mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 3.464: | Regel 3.433: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 3.475: | Regel 3.444: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /><section begin=mbhs-mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.2b - MBH_300_wijzigen_verhoging==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verhoging_MA_wijzigingmetVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.499: | Regel 3.468: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T om 09:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 3.521: | Regel 3.487: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.533: | Regel 3.502: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.539: | Regel 3.508: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verhoging_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.552: | Regel 3.528: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 08:02 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 09:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.563: | Regel 3.553: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Bouwstenen ==== | + | {| class="wikitable" width="85%" |
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_wijzigen_verhoging_VV_extra | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 08:02 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|60 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| Regel 3.598: | Regel 3.637: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 3.618: | Regel 3.657: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.632: | Regel 3.671: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.645: | Regel 3.684: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |}<section end=mbhs-mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /><section end=mv-mp-vo-tst-3-2b-wijzigen-verhoging-v30 /> |
| − | == TEST Scenarioset 3 Wijzigen (verlaging)== | + | == TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)== |
| − | <section begin=mv-mp-vo-tst-3- | + | <section begin=mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /><section begin=patient-mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 3.667: | Regel 3.706: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 3.678: | Regel 3.717: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /><section begin=mbhs-mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.3a - MBH_300_wijzigen_verlaging==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verlaging_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.702: | Regel 3.741: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 27 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 3.724: | Regel 3.763: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.739: | Regel 3.775: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.745: | Regel 3.781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 3.758: | Regel 3.787: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_wijzigen_verlaging_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.765: | Regel 3.794: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Auteur | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.790: | Regel 3.805: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|20 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.797: | Regel 3.815: | ||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RelatieMedicatieafspraak |
|style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.832: | Regel 3.840: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 3.852: | Regel 3.860: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.866: | Regel 3.874: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 3 ( | + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
| − | <section begin=mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /><section end=mv-mp-vo-tst-3-3a-wijzigen-verlaging-v30 /> | ||
| + | == TEST Scenarioset 3 Wijzigen (verlaging)== | ||
| + | <section begin=mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /><section begin=patient-mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 3.888: | Regel 3.909: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 3.899: | Regel 3.920: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /><section begin=mbhs-mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.3b - MBH_300_wijzigen_verlaging==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.923: | Regel 3.944: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 6 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 3.945: | Regel 3.966: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.957: | Regel 3.981: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.963: | Regel 3.987: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigen_verlaging_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.976: | Regel 4.007: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 08:10 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 6 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 6 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.987: | Regel 4.032: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|MBH identificatie | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.022: | Regel 4.074: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.042: | Regel 4.094: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.056: | Regel 4.108: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | + | |}<section end=mbhs-mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /><section end=mv-mp-vo-tst-3-3b-wijzigen-verlaging-v30 /> | |
| − | + | == TEST Scenarioset 3 (initieren scenario) Onderbreken== | |
| − | + | <section begin=mv-mp-vo-tst-3-4a-onderbreken-v30 /><section begin=patient-mv-mp-vo-tst-3-4a-onderbreken-v30 /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | ||
| − | == TEST Scenarioset 3 Onderbreken== | ||
| − | <section begin=mv-mp-vo-tst-3- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.091: | Regel 4.130: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.102: | Regel 4.141: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-4a-onderbreken-v30 /><section begin=mbhs-mv-mp-vo-tst-3-4a-onderbreken-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.4a - MBH_300_onderbreken==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_onderbreken_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.126: | Regel 4.165: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 15:00 uur'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 10 dagen om 15:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.140: | Regel 4.179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T om 15:00 uur | + | |style="background-color: white;"|T + 10 dagen om 15:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 4.151: | Regel 4.187: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 4.169: | Regel 4.202: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_onderbreken_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 08:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Zorgverlener | + | |colspan="2"|Zorgverlener |
| − | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.216: | Regel 4.284: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.230: | Regel 4.298: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 3 | + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
| − | <section begin=mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-3-4a-onderbreken-v30 /><section end=mv-mp-vo-tst-3-4a-onderbreken-v30 /> | ||
| + | == TEST Scenarioset 3 Onderbreken== | ||
| + | <section begin=mv-mp-vo-tst-3-4b-onderbreken-v30 /><section begin=patient-mv-mp-vo-tst-3-4b-onderbreken-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.252: | Regel 4.333: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.263: | Regel 4.344: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-4b-onderbreken-v30 /><section begin=mbhs-mv-mp-vo-tst-3-4b-onderbreken-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.4b - MBH_300_onderbreken==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_onderbreken_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.287: | Regel 4.368: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 18:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T om 15:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.300: | Regel 4.381: | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T om 15:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 4.309: | Regel 4.393: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.321: | Regel 4.408: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.386: | Regel 4.438: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.406: | Regel 4.458: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.420: | Regel 4.472: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | + | |}<section end=mbhs-mv-mp-vo-tst-3-4b-onderbreken-v30 /><section end=mv-mp-vo-tst-3-4b-onderbreken-v30 /> | |
| − | + | == TEST Scenarioset 3 TA wijzigen (onveranderde MA)== | |
| − | + | <section begin=mv-mp-vo-tst-3-5-wijzigenTA-v30 /><section begin=patient-mv-mp-vo-tst-3-5-wijzigenTA-v30 /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | ||
| − | == TEST Scenarioset 3 ( | ||
| − | <section begin=mv-mp-vo-tst-3- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.455: | Regel 4.494: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.466: | Regel 4.505: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-5-wijzigenTA-v30 /><section begin=mbhs-mv-mp-vo-tst-3-5-wijzigenTA-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.5 - MBH_300_TAwijzigen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_TAwijzigen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.490: | Regel 4.529: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 4.514: | Regel 4.553: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.524: | Regel 4.563: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_TAwijzigen_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.543: | Regel 4.582: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 4.555: | Regel 4.594: | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.571: | Regel 4.610: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.589: | Regel 4.628: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.609: | Regel 4.648: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.623: | Regel 4.662: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.636: | Regel 4.675: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |}<section end=mbhs-mv-mp-vo-tst-3-5-wijzigenTA-v30 /><section end=mv-mp-vo-tst-3-5-wijzigenTA-v30 /> |
| − | == TEST Scenarioset 3 annuleren== | + | == TEST Scenarioset 3 (initieren scenario) annuleren== |
| − | <section begin=mv-mp-vo-tst-3- | + | <section begin=mv-mp-vo-tst-3-6a-annuleren-v30 /><section begin=patient-mv-mp-vo-tst-3-6a-annuleren-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.658: | Regel 4.697: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.669: | Regel 4.708: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-6a-annuleren-v30 /><section begin=mbhs-mv-mp-vo-tst-3-6a-annuleren-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.6a - MBH_300_annuleren==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_annuleren_MA_starten |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.693: | Regel 4.732: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 14:10 uur | |style="background-color: white;"|T om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 7 dagen, tot en met T + 49 dagen om 00:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 49 dagen om 00:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 4.718: | Regel 4.754: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 4.740: | Regel 4.773: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per week 1 stuk | |style="background-color: white;"|1 maal per week 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_annuleren_VV_starten | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_annuleren_VV_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgverlener |
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|42 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem '<span title="2.16.840.1.113883.2.4.4.1">G-Standaard GPK</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
|style="background-color: white;"|MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.763: | Regel 4.831: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.783: | Regel 4.851: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.797: | Regel 4.865: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 3 | + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
| − | <section begin=mv-mp-vo-tst-3- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-3-6a-annuleren-v30 /><section end=mv-mp-vo-tst-3-6a-annuleren-v30 /> | ||
| + | == TEST Scenarioset 3 annuleren== | ||
| + | <section begin=mv-mp-vo-tst-3-6b-annuleren-v30 /><section begin=patient-mv-mp-vo-tst-3-6b-annuleren-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.819: | Regel 4.900: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.830: | Regel 4.911: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-6b-annuleren-v30 /><section begin=mbhs-mv-mp-vo-tst-3-6b-annuleren-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.6b - MBH_300_annuleren==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_annuleren_MA_geannuleerd |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.854: | Regel 4.935: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_MA_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 14:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 4 dagen, tot en met T + 4 dagen om 00:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 4 dagen om 00:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 4.876: | Regel 4.960: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|Overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Neuropsychiatrische effecten | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem '<span title="2.16.840.1.113883.2.4.4.1">G-Standaard GPK</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.888: | Regel 4.975: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 4.894: | Regel 4.981: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 4.953: | Regel 5.005: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Bertine van | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 4.973: | Regel 5.025: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.987: | Regel 5.039: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | + | |}<section end=mbhs-mv-mp-vo-tst-3-6b-annuleren-v30 /><section end=mv-mp-vo-tst-3-6b-annuleren-v30 /> | |
| − | + | == TEST Scenarioset 3 (initieren scenario) VolgendeBehandelaar== | |
| − | + | <section begin=mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /><section begin=patient-mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | ||
| − | == TEST Scenarioset 3 ( | ||
| − | <section begin=mv-mp-vo-tst-3- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 5.022: | Regel 5.061: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.033: | Regel 5.072: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /><section begin=mbhs-mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.7a - MBH_300_VolgendeBehandelaar==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Start1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.057: | Regel 5.096: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 100 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 5.081: | Regel 5.117: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.104: | Regel 5.137: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VolgendeBehandelaar_VV_Start1 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_VV_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgverlener |
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|100 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
|style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.123: | Regel 5.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Contactgegevens | |colspan="5"|Contactgegevens | ||
| Regel 5.145: | Regel 5.213: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Telefoonnummer | |colspan="2"|Telefoonnummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1634534000 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.155: | Regel 5.223: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
| − | |style="background-color: white;"|Werkadres: | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |}<section end=mbhs-mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /><section end=mv-mp-vo-tst-3-7a-volgendeBehandelaar-v30 /> |
| − | == TEST Scenarioset 3 VolgendeBehandelaar== | + | == TEST Scenarioset 3 (stoppen scenario) VolgendeBehandelaar== |
| − | <section begin=mv-mp-vo-tst-3- | + | <section begin=mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /><section begin=patient-mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 5.186: | Regel 5.264: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.197: | Regel 5.275: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /><section begin=mbhs-mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.7b - MBH_300_VolgendeBehandelaar==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Stop1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.221: | Regel 5.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Stop1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 49 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 49 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 5.243: | Regel 5.324: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|RedenWijzigenOfStaken | |
| − | + | |style="background-color: white;"|opname in instelling (code = '305335007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |
| − | |||
| − | |||
| − | |||
| − | |colspan="3"| | ||
| − | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.273: | Regel 5.347: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 5.283: | Regel 5.357: | ||
|style="background-color: white;"|MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="5" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="JAN_VAN_HARTEN" title="Intern ID = JAN_VAN_HARTEN">Zorgverlener JAN_VAN_HARTEN</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="13"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|ZorgverlenerIdentificatienummer | |
| − | + | |style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"| | ||
| − | |style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| Regel 5.357: | Regel 5.389: | ||
|style="background-color: white;"|1634534321 | |style="background-color: white;"|1634534321 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.366: | Regel 5.398: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] | |style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> | |colspan="6"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> | ||
| Regel 5.391: | Regel 5.403: | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00004444 (in identificerend systeem: URA) | |style="background-color: white;"|00004444 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Ziekenhuis het Gele Hart | |style="background-color: white;"|Ziekenhuis het Gele Hart | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.400: | Regel 5.412: | ||
|style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad | |style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieType |
|style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /><section end=mv-mp-vo-tst-3-7b-volgendeBehandelaar-v30 /> | ||
| + | == TEST Scenarioset 3 VolgendeBehandelaar== | ||
| + | <section begin=mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /><section begin=patient-mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|Naamgebruik | |
| − | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 5.453: | Regel 5.439: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst-3- | + | |}<section end=patient-mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /><section begin=mbhs-mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /> |
| − | ==== Scenario 3. | + | ==== Scenario 3.7c - MBH_300_VolgendeBehandelaar==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Start2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.477: | Regel 5.463: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 4 dagen, tot en met T + 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 51 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 5.499: | Regel 5.485: | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|VolgendeBehandelaar | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR|Zorgverlener: BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|hervatten van beleid van vorige voorschrijver (code = '112261000146100' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 5.511: | Regel 5.507: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.517: | Regel 5.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 stuk | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VolgendeBehandelaar_VV_Start2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.530: | Regel 5.533: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_VV_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 5.542: | Regel 5.545: | ||
|style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|47 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 5.558: | Regel 5.561: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar_MA_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.576: | Regel 5.579: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.596: | Regel 5.599: | ||
|style="background-color: white;"|1634534321 | |style="background-color: white;"|1634534321 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.605: | Regel 5.608: | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] | |style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR" title="Intern ID = BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR">Zorgverlener BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> | |colspan="6"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> | ||
| Regel 5.610: | Regel 5.633: | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00004444 (in identificerend systeem: URA) | |style="background-color: white;"|00004444 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Ziekenhuis het Gele Hart | |style="background-color: white;"|Ziekenhuis het Gele Hart | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.619: | Regel 5.642: | ||
|style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad | |style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieType |
|style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | |style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| Regel 5.626: | Regel 5.662: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-3- | + | |}<section end=mbhs-mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /><section end=mv-mp-vo-tst-3-7c-volgendeBehandelaar-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 3 Stoppen parallelle TA (onveranderde MA)== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /><section begin=patient-mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 5.646: | Regel 5.682: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.656: | Regel 5.692: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /><section begin=mbhs-mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /> |
| − | ==== Scenario | + | ==== Scenario 3.8 - MBH_300_stoppen_parallele_TA==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_stoppen_parallele_TA_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.680: | Regel 5.719: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende | + | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 5.694: | Regel 5.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 5.701: | Regel 5.740: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 5.714: | Regel 5.753: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 stuk 's ochtends en Bij pijn 1 stuk 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 stuk 's ochtends en Bij pijn 1 stuk 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_stoppen_parallele_TA_VV_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.733: | Regel 5.772: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_VV_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 5.743: | Regel 5.782: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 5.761: | Regel 5.800: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.803: | Regel 5.814: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="JAN_VAN_HARTEN" title="Intern ID = JAN_VAN_HARTEN">Zorgverlener JAN_VAN_HARTEN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jan van Harten |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Contactgegevens | |colspan="5"|Contactgegevens | ||
| Regel 5.825: | Regel 5.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Telefoonnummer | |colspan="2"|Telefoonnummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1634534321 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.835: | Regel 5.846: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00004444 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ziekenhuis het Gele Hart |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
| − | |style="background-color: white;"|Werkadres: | + | |style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieType | ||
| + | |style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| Regel 5.854: | Regel 5.868: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | + | |}<section end=mbhs-mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /><section end=mv-mp-vo-tst-3-8-Stoppen-parallelle-TA-v30 /> | |
| − | + | == TEST Scenarioset 4 Lengte Gewicht== | |
| − | + | <section begin=mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /><section begin=patient-mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |}<section end=mbhs-mv-mp-vo-tst- | ||
| − | == TEST Scenarioset 4 Lengte | ||
| − | <section begin=mv-mp-vo-tst-4-1- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 5.917: | Regel 5.911: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-4-1- | + | |}<section end=patient-mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /><section begin=mbhs-mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /> |
| − | ==== Scenario 4. | + | ==== Scenario 4.1a - MBH_300_VOS_Lengte_Gewicht==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 5.930: | Regel 5.924: | ||
|style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 10:00 uur | |style="background-color: white;"|T om 10:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.973: | Regel 5.967: | ||
|style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VOS_Lengte_Gewicht_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T om 10:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|14 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Lichaamslengte ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Lichaamslengte | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="2" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|LengteWaarde | ||
| + | |style="background-color: white;"|164 cm | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|LengteDatumTijd | ||
| + | |style="background-color: white;"|T - 12 dagen om 13:14 uur | ||
| + | |} | ||
| + | ==== Lichaamsgewicht ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Lichaamsgewicht | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="2" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|GewichtWaarde |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|102 kg |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|GewichtDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 12 dagen om 13:20 uur |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.019: | Regel 6.049: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 6.039: | Regel 6.069: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.053: | Regel 6.083: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.062: | Regel 6.092: | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"| | + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Lichaamslengte | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|LengteWaarde |
|style="background-color: white;"|164 cm | |style="background-color: white;"|164 cm | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|LengteDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 12 dagen om 13:14 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="6"|Lichaamsgewicht | |colspan="6"|Lichaamsgewicht | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GewichtWaarde |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|102 kg |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GewichtDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 12 dagen om 13:20 uur |
| − | + | |}<section end=mbhs-mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /><section end=mv-mp-vo-tst-4-1-a-lengte-gewicht-v30 /> | |
| − | + | == TEST Scenarioset 4 Lengte gewicht persistent== | |
| − | + | <section begin=mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /><section begin=patient-mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /> | |
| − | |}<section end=mbhs-mv-mp-vo-tst-4-1- | ||
| − | == TEST Scenarioset 4 | ||
| − | <section begin=mv-mp-vo-tst-4- | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.122: | Regel 6.159: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-4- | + | |}<section end=patient-mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /><section begin=mbhs-mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /> |
| − | ==== Scenario 4. | + | ==== Scenario 4.1b - MBH_300_VOS_Lengte_Gewicht==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VOS_Lengte_Gewicht_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.133: | Regel 6.170: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 2 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Gebruiksduur | ||
| + | |style="background-color: white;"|2 weken | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 6.154: | Regel 6.194: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.164: | Regel 6.204: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| Regel 6.173: | Regel 6.213: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VOS_Lengte_Gewicht_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.183: | Regel 6.223: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 6.195: | Regel 6.235: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|14 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 6.211: | Regel 6.251: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| + | |} | ||
| + | ==== Lichaamslengte ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Lichaamslengte | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="2" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatienummer | ||
| + | |style="background-color: white;"|test-id-lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|LengteWaarde | ||
| + | |style="background-color: white;"|164 cm | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|LengteDatumTijd | ||
| + | |style="background-color: white;"|T om 07:05 uur | ||
| + | |} | ||
| + | ==== Lichaamsgewicht ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Lichaamsgewicht | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="2" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatienummer | ||
| + | |style="background-color: white;"|test-id-gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|GewichtWaarde | ||
| + | |style="background-color: white;"|98 kg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|GewichtDatumTijd | ||
| + | |style="background-color: white;"|T om 07:05 uur | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.229: | Regel 6.303: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 6.249: | Regel 6.323: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.263: | Regel 6.337: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.276: | Regel 6.350: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-4- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 4 Nierfunctie | + | |colspan="6"|Lichaamslengte |
| − | <section begin=mv-mp-vo-tst-4-2- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|test-id-lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|LengteWaarde | ||
| + | |style="background-color: white;"|164 cm | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|LengteDatumTijd | ||
| + | |style="background-color: white;"|T om 07:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Lichaamsgewicht | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|test-id-gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GewichtWaarde | ||
| + | |style="background-color: white;"|98 kg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GewichtDatumTijd | ||
| + | |style="background-color: white;"|T om 07:05 uur | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /><section end=mv-mp-vo-tst-4-1-b-lengte-gewicht-persistent-v30 /> | ||
| + | == TEST Scenarioset 4 Nierfunctie NHG== | ||
| + | <section begin=mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /><section begin=patient-mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.319: | Regel 6.419: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-4-2- | + | |}<section end=patient-mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /><section begin=mbhs-mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /> |
| − | ==== Scenario 4. | + | ==== Scenario 4.2a - MBH_300_VOS_Lab==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VOS_Lab_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.330: | Regel 6.430: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 07:05 uur | |style="background-color: white;"|T om 07:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.351: | Regel 6.451: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.370: | Regel 6.470: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VOS_Lab_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.380: | Regel 6.480: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 07:05 uur | |style="background-color: white;"|T om 07:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.392: | Regel 6.492: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|180 stuks | |style="background-color: white;"|180 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 6.408: | Regel 6.508: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.426: | Regel 6.526: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 6.446: | Regel 6.546: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.460: | Regel 6.560: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.473: | Regel 6.573: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-4-2- | + | |}<section end=mbhs-mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /><section end=mv-mp-vo-tst-4-2-a-nierfunctie-NHG-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 4 Nierfunctie Loinc zonder panel== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /><section begin=patient-mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.496: | Regel 6.596: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|E. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 6.506: | Regel 6.606: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Doppen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900511 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|24 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /><section begin=mbhs-mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /> |
| − | ==== Scenario | + | ==== Scenario 4.2b - MBH_300_VOS_Lab==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VOS_Lab_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.527: | Regel 6.627: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 07:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 6.551: | Regel 6.648: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.561: | Regel 6.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VOS_Lab_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.580: | Regel 6.677: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 07:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 6.592: | Regel 6.689: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|180 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 6.608: | Regel 6.705: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.626: | Regel 6.723: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 6.646: | Regel 6.743: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.660: | Regel 6.757: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.673: | Regel 6.770: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /><section end=mv-mp-vo-tst-4-2-b-nierfunctie-loinc-zonder-panel-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Variabele frequentie== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-1-variabele-frequentie-v30 /><section begin=patient-mv-mp-vo-tst-6-1-variabele-frequentie-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.716: | Regel 6.813: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-1-variabele-frequentie-v30 /><section begin=mbhs-mv-mp-vo-tst-6-1-variabele-frequentie-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.1 - MBH_300_variabelefrequentie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_variabelefrequentie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.727: | Regel 6.824: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 16 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 6.748: | Regel 6.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.758: | Regel 6.858: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.764: | Regel 6.864: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_variabelefrequentie_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.777: | Regel 6.877: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 6.789: | Regel 6.889: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 6.805: | Regel 6.905: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.823: | Regel 6.923: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 6.843: | Regel 6.943: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.857: | Regel 6.957: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.870: | Regel 6.970: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-1-variabele-frequentie-v30 /><section end=mv-mp-vo-tst-6-1-variabele-frequentie-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Interval== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-2-interval-v30 /><section begin=patient-mv-mp-vo-tst-6-2-interval-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.913: | Regel 7.013: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-2-interval-v30 /><section begin=mbhs-mv-mp-vo-tst-6-2-interval-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.2 - MBH_300_interval==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_interval_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.924: | Regel 7.024: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 6.948: | Regel 7.045: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.958: | Regel 7.055: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_interval_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.977: | Regel 7.074: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:04 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 6.989: | Regel 7.086: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 7.005: | Regel 7.102: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 7.023: | Regel 7.120: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 7.043: | Regel 7.140: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.057: | Regel 7.154: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.070: | Regel 7.167: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-2-interval-v30 /><section end=mv-mp-vo-tst-6-2-interval-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Variabele hoeveelheid== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /><section begin=patient-mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.113: | Regel 7.210: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /><section begin=mbhs-mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.3 - MBH_300_variabelehoeveelheid==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_variabelehoeveelheid_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.124: | Regel 7.221: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| Regel 7.148: | Regel 7.245: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|3 maal per dag, | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|3 maal per dag | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_variabelehoeveelheid_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.180: | Regel 7.274: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 7.192: | Regel 7.286: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"|100 | + | |style="background-color: white;"|100 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 7.208: | Regel 7.302: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 7.226: | Regel 7.320: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 7.246: | Regel 7.340: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.260: | Regel 7.354: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.273: | Regel 7.367: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /><section end=mv-mp-vo-tst-6-3-variabele-hoeveelheid-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Zonder keerdosis== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /><section begin=patient-mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.316: | Regel 7.410: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /><section begin=mbhs-mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.4 - MBH_300_zonderkeerdosis==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_zonderkeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.327: | Regel 7.421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| Regel 7.351: | Regel 7.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_zonderkeerdosis_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.380: | Regel 7.477: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 7.392: | Regel 7.489: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 7.408: | Regel 7.505: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 7.426: | Regel 7.523: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 7.446: | Regel 7.543: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.460: | Regel 7.557: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.473: | Regel 7.570: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /><section end=mv-mp-vo-tst-6-4-zonder-keerdosis-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Bijzondere keerdosis== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /><section begin=patient-mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.516: | Regel 7.613: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /><section begin=mbhs-mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.5 - MBH_300_bijzonderekeerdosis==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_bijzonderekeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.527: | Regel 7.624: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| Regel 7.551: | Regel 7.648: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_bijzonderekeerdosis_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.586: | Regel 7.677: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 7.598: | Regel 7.689: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 7.614: | Regel 7.705: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 7.632: | Regel 7.723: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 7.652: | Regel 7.743: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.666: | Regel 7.757: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.679: | Regel 7.770: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /><section end=mv-mp-vo-tst-6-5-bijzondere-keerdosis-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Variabele hoeveelheid 2== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /><section begin=patient-mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.722: | Regel 7.813: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /><section begin=mbhs-mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.6 - MBH_300_variabelehoeveelheid2==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_variabelehoeveelheid2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.733: | Regel 7.824: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 7.747: | Regel 7.838: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 7.757: | Regel 7.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_variabelehoeveelheid2_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.786: | Regel 7.883: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 7.798: | Regel 7.895: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|450 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 7.814: | Regel 7.911: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 7.832: | Regel 7.929: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 7.852: | Regel 7.949: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.866: | Regel 7.963: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.879: | Regel 7.976: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /><section end=mv-mp-vo-tst-6-6-variabele-hoeveelheid-2-v30 /> |
| − | == TEST Scenarioset 6 Tijdstippen | + | == TEST Scenarioset 6 Tijdstippen flexibel== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /><section begin=patient-mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.922: | Regel 8.019: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /><section begin=mbhs-mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.7a - MBH_300_tijdstippen_flexibel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_tijdstippen_flexibel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.933: | Regel 8.030: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 7.947: | Regel 8.044: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 7.967: | Regel 8.064: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|elke dag om | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|elke dag om | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_tijdstippen_flexibel_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.986: | Regel 8.083: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 7.998: | Regel 8.095: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|45 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.007: | Regel 8.104: | ||
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.014: | Regel 8.111: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.032: | Regel 8.129: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 8.052: | Regel 8.149: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.066: | Regel 8.163: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.079: | Regel 8.176: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /><section end=mv-mp-vo-tst-6-7a-tijdstippen-flexibel-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Tijdstippen niet flexibel== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section begin=patient-mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.122: | Regel 8.219: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section begin=mbhs-mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_tijdstippen_niet_flexibel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.133: | Regel 8.230: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 8.147: | Regel 8.244: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 8.157: | Regel 8.254: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|op | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|op | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_tijdstippen_niet_flexibel_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.192: | Regel 8.283: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 8.204: | Regel 8.295: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|24 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.220: | Regel 8.311: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.238: | Regel 8.329: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 8.258: | Regel 8.349: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.272: | Regel 8.363: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.285: | Regel 8.376: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /><section end=mv-mp-vo-tst-6-7b-tijdstippen-niet-flexibel-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Weekdagen== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-8-weekdagen-v30 /><section begin=patient-mv-mp-vo-tst-6-8-weekdagen-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.328: | Regel 8.419: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-8-weekdagen-v30 /><section begin=mbhs-mv-mp-vo-tst-6-8-weekdagen-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.8 - MBH_300_weekdagen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_weekdagen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.339: | Regel 8.430: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 70 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 8.360: | Regel 8.454: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Doseerinstructie | + | |colspan="2"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_weekdagen_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.389: | Regel 8.489: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_weekdagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 8.401: | Regel 8.501: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.417: | Regel 8.517: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.435: | Regel 8.535: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 8.455: | Regel 8.555: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.469: | Regel 8.569: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.482: | Regel 8.582: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-8-weekdagen-v30 /><section end=mv-mp-vo-tst-6-8-weekdagen-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Dagdeel== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-9-dagdeel-v30 /><section begin=patient-mv-mp-vo-tst-6-9-dagdeel-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.525: | Regel 8.625: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-9-dagdeel-v30 /><section begin=mbhs-mv-mp-vo-tst-6-9-dagdeel-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.9 - MBH_300_dagdeel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_dagdeel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.536: | Regel 8.636: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:27 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| Regel 8.557: | Regel 8.657: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.573: | Regel 8.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_dagdeel_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.589: | Regel 8.686: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_dagdeel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:27 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 8.601: | Regel 8.698: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|60 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.617: | Regel 8.714: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.635: | Regel 8.732: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 8.655: | Regel 8.752: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.669: | Regel 8.766: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.682: | Regel 8.779: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-9-dagdeel-v30 /><section end=mv-mp-vo-tst-6-9-dagdeel-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Cyclisch schema== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-10-cyclisch-schema-v30 /><section begin=patient-mv-mp-vo-tst-6-10-cyclisch-schema-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.725: | Regel 8.822: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-10-cyclisch-schema-v30 /><section begin=mbhs-mv-mp-vo-tst-6-10-cyclisch-schema-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.10 - MBH_300_cyclischschema==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_cyclischschema_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.736: | Regel 8.833: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:33 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 8.760: | Regel 8.854: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|HerhaalperiodeCyclischSchema |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_cyclischschema_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.795: | Regel 8.886: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_cyclischschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:33 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 8.807: | Regel 8.898: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|126 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.823: | Regel 8.914: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.841: | Regel 8.932: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 8.861: | Regel 8.952: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.875: | Regel 8.966: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.888: | Regel 8.979: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-10-cyclisch-schema-v30 /><section end=mv-mp-vo-tst-6-10-cyclisch-schema-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Afbouwschema== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-11-afbouwschema-v30 /><section begin=patient-mv-mp-vo-tst-6-11-afbouwschema-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.931: | Regel 9.022: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-11-afbouwschema-v30 /><section begin=mbhs-mv-mp-vo-tst-6-11-afbouwschema-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.11 - MBH_300_afbouwschema==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_afbouwschema_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.942: | Regel 9.033: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:40 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 8.956: | Regel 9.047: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 41 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 8.966: | Regel 9.057: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie 1 | ||
| + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Doseerinstructie | + | |colspan="2"|Doseerinstructie 3 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_afbouwschema_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.995: | Regel 9.092: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_afbouwschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:40 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 9.007: | Regel 9.104: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|90 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 9.023: | Regel 9.120: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.041: | Regel 9.138: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 9.061: | Regel 9.158: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.075: | Regel 9.172: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.088: | Regel 9.185: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-11-afbouwschema-v30 /><section end=mv-mp-vo-tst-6-11-afbouwschema-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Variabele hoeveelheid en maximum== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section begin=patient-mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.131: | Regel 9.228: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section begin=mbhs-mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_variabelehoeveelheidenmaximum_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.142: | Regel 9.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 9.156: | Regel 9.253: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 9.166: | Regel 9.263: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 9.176: | Regel 9.273: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_variabelehoeveelheidenmaximum_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.195: | Regel 9.292: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 9.207: | Regel 9.304: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|120 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 9.223: | Regel 9.320: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.241: | Regel 9.338: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 9.261: | Regel 9.358: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.275: | Regel 9.372: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.288: | Regel 9.385: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /><section end=mv-mp-vo-tst-6-12-variabele-hoeveelheid-en-maximum-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Toedieningssnelheid== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /><section begin=patient-mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.331: | Regel 9.428: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /><section begin=mbhs-mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.13 - MBH_300_toedieningssnelheid==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_toedieningssnelheid_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.342: | Regel 9.439: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:47 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 8 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 9.363: | Regel 9.463: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 9.373: | Regel 9.473: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h, parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_toedieningssnelheid_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.392: | Regel 9.492: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:47 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 9.404: | Regel 9.504: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|100 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 9.420: | Regel 9.520: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.438: | Regel 9.538: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 9.458: | Regel 9.558: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.472: | Regel 9.572: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.485: | Regel 9.585: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /><section end=mv-mp-vo-tst-6-13-toedieningssnelheid-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Toedieningsduur== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-14-toedieningsduur-v30 /><section begin=patient-mv-mp-vo-tst-6-14-toedieningsduur-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.528: | Regel 9.628: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-14-toedieningsduur-v30 /><section begin=mbhs-mv-mp-vo-tst-6-14-toedieningsduur-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.14 - MBH_300_toedieningsduur==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_toedieningsduur_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.539: | Regel 9.639: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:49 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 9.563: | Regel 9.660: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 9.573: | Regel 9.670: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur, transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_toedieningsduur_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.592: | Regel 9.689: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningsduur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:49 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 9.604: | Regel 9.701: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|30 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 9.620: | Regel 9.717: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.638: | Regel 9.735: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 9.658: | Regel 9.755: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.672: | Regel 9.769: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.685: | Regel 9.782: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-14-toedieningsduur-v30 /><section end=mv-mp-vo-tst-6-14-toedieningsduur-v30 /> |
| − | == TEST Scenarioset 6 | + | == TEST Scenarioset 6 Zo nodig== |
| − | <section begin=mv-mp-vo-tst-6- | + | <section begin=mv-mp-vo-tst-6-15-zonodig-v30 /><section begin=patient-mv-mp-vo-tst-6-15-zonodig-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.728: | Regel 9.825: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-6- | + | |}<section end=patient-mv-mp-vo-tst-6-15-zonodig-v30 /><section begin=mbhs-mv-mp-vo-tst-6-15-zonodig-v30 /> |
| − | ==== Scenario 6. | + | ==== Scenario 6.15 - MBH_300_zonodig==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_zonodig_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.739: | Regel 9.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:57 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 9.752: | Regel 9.849: | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 27 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 9.763: | Regel 9.860: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 9.773: | Regel 9.870: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_zonodig_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.792: | Regel 9.889: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonodig_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:57 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 9.804: | Regel 9.901: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|14 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 9.820: | Regel 9.917: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.838: | Regel 9.935: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 9.858: | Regel 9.955: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.872: | Regel 9.969: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.885: | Regel 9.982: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-6- | + | |}<section end=mbhs-mv-mp-vo-tst-6-15-zonodig-v30 /><section end=mv-mp-vo-tst-6-15-zonodig-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 6 Trombosedienst== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-6-16-trombosedienst-v30 /><section begin=patient-mv-mp-vo-tst-6-16-trombosedienst-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.918: | Regel 10.015: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-6-16-trombosedienst-v30 /><section begin=mbhs-mv-mp-vo-tst-6-16-trombosedienst-v30 /> |
| − | ==== Scenario | + | ==== Scenario 6.16 - MBH_300_WDS_trombose_medicatie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_WDS_trombose_medicatie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_trombose_medicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|FYTOMENADION TABLET 1MG (code = '106720' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FYTOMENADION TABLET 1MG (code = '142697' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4 | + | |colspan="4"|Gebruiksinstructie |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|5 stuks 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|5 stuks 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_trombose_medicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_WDS_trombose_medicatie_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_trombose_medicatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|10 stuks |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|FYTOMENADION TABLET 1MG (code = '106720' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | + | |style="background-color: white;"|FYTOMENADION TABLET 1MG (code = '142697' in codeSystem 'G-Standaard GPK') | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |style="background-color: white;"| | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_trombose_medicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_trombose_medicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.088: | Regel 10.135: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 10.108: | Regel 10.155: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.122: | Regel 10.169: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.135: | Regel 10.182: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-6-16-trombosedienst-v30 /><section end=mv-mp-vo-tst-6-16-trombosedienst-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 6 redundante frequentie== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-6-17-redundante-frequentie-v30 /><section begin=patient-mv-mp-vo-tst-6-17-redundante-frequentie-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 10.168: | Regel 10.215: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-6-17-redundante-frequentie-v30 /><section begin=mbhs-mv-mp-vo-tst-6-17-redundante-frequentie-v30 /> |
| − | ==== Scenario | + | ==== Scenario 6.17 - MBH_300_redundantefrequentie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_redundantefrequentie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redundantefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T om 09:00 uur, gedurende 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4 | + | |colspan="4"|Gebruiksinstructie |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"|1 maal per dag, | + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redundantefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_redundantefrequentie_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redundantefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|14 stuks |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redundantefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redundantefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.316: | Regel 10.335: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 10.336: | Regel 10.355: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.350: | Regel 10.369: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.363: | Regel 10.382: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-6-17-redundante-frequentie-v30 /><section end=mv-mp-vo-tst-6-17-redundante-frequentie-v30 /> |
| − | == TEST Scenarioset 7 | + | == TEST Scenarioset 7 Alle ingrediënten== |
| − | <section begin=mv-mp-vo-tst-7- | + | <section begin=mv-mp-vo-tst-7-1-alle-ingredienten-v30 /><section begin=patient-mv-mp-vo-tst-7-1-alle-ingredienten-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 10.406: | Regel 10.425: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-7- | + | |}<section end=patient-mv-mp-vo-tst-7-1-alle-ingredienten-v30 /><section begin=mbhs-mv-mp-vo-tst-7-1-alle-ingredienten-v30 /> |
| − | ==== Scenario 7. | + | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_magistraalalleingredienten_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 10.417: | Regel 10.436: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 12: | + | |style="background-color: white;"|T om 12:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 10.431: | Regel 10.450: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 31 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 10.440: | Regel 10.459: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="11"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.457: | Regel 10.473: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Sterkte | |colspan="2"|Sterkte | ||
|style="background-color: white;"|10 gram per 100 gram | |style="background-color: white;"|10 gram per 100 gram | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Ingredient | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|IngredientCode | ||
| + | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Sterkte | ||
| + | |style="background-color: white;"|90 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 10.468: | Regel 10.494: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G- | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_magistraalalleingredienten_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 10.487: | Regel 10.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om 12: | + | |style="background-color: white;"|T om 12:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
| Regel 10.499: | Regel 10.525: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|50 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="11"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.519: | Regel 10.542: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.525: | Regel 10.548: | ||
|style="background-color: white;"|10 gram per 100 gram | |style="background-color: white;"|10 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="4"|Ingredient |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|IngredientCode | ||
| + | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Sterkte | ||
| + | |style="background-color: white;"|90 gram per 100 gram | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|BeoogdVerstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 10.532: | Regel 10.565: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.550: | Regel 10.583: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 10.570: | Regel 10.603: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.584: | Regel 10.617: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.597: | Regel 10.630: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-7- | + | |}<section end=mbhs-mv-mp-vo-tst-7-1-alle-ingredienten-v30 /><section end=mv-mp-vo-tst-7-1-alle-ingredienten-v30 /> |
| − | == TEST Scenarioset 7 | + | == TEST Scenarioset 7 Actief ingrediënt == |
| − | <section begin=mv-mp-vo-tst-7- | + | <section begin=mv-mp-vo-tst-7-2-actief-ingredient-v30 /><section begin=patient-mv-mp-vo-tst-7-2-actief-ingredient-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 10.640: | Regel 10.673: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-7- | + | |}<section end=patient-mv-mp-vo-tst-7-2-actief-ingredient-v30 /><section begin=mbhs-mv-mp-vo-tst-7-2-actief-ingredient-v30 /> |
| − | ==== Scenario 7. | + | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_magistraalactieveingredient_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 70 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ProductNaam | ||
| + | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Sterkte |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|80 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_magistraalactieveingredient_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="4"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|75 gram |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ProductNaam | ||
| + | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Sterkte |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|80 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.758: | Regel 10.811: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 10.778: | Regel 10.831: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.792: | Regel 10.845: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.805: | Regel 10.858: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-7- | + | |}<section end=mbhs-mv-mp-vo-tst-7-2-actief-ingredient-v30 /><section end=mv-mp-vo-tst-7-2-actief-ingredient-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 7 90 miljoen nummer== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /><section begin=patient-mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 10.828: | Regel 10.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 10.838: | Regel 10.891: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hess |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900614 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /><section begin=mbhs-mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /> |
| − | ==== Scenario | + | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_magistraal90miljoennr_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:08 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="8"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ProductCode | ||
| + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ProductNaam | ||
| + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Ingredient | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|IngredientCode |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Sterkte |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|10 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_300_magistraal90miljoennr_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:08 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|TeVerstrekkenHoeveelheid |
| − | + | |style="background-color: white;"|100 gram | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="8"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ProductCode |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|MBH identificatie | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Ingredient | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|IngredientCode | ||
| + | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Sterkte | ||
| + | |style="background-color: white;"|10 gram per 100 gram | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.954: | Regel 11.041: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 10.976: | Regel 11.063: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Telefoonnummer | |colspan="2"|Telefoonnummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1645645000 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.992: | Regel 11.079: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 11.005: | Regel 11.092: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /><section end=mv-mp-vo-tst-7-3-90-miljoen-nummer-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 7 vrije tekst product== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-7-4-vrije-tekst-v30 /><section begin=patient-mv-mp-vo-tst-7-4-vrije-tekst-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 11.028: | Regel 11.115: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|G. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 11.038: | Regel 11.125: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hess |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900614 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-7-4-vrije-tekst-v30 /><section begin=mbhs-mv-mp-vo-tst-7-4-vrije-tekst-v30 /> |
| − | ==== Scenario | + | ==== Scenario 7.4 - MBH_300_vrijetekstproduct==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_vrijetekstproduct_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.059: | Regel 11.146: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 14:52 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, gedurende 12 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|12 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 11.080: | Regel 11.167: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="3"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ProductNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jemperli 500 mg/ 10 mL |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 11.093: | Regel 11.184: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per 3 weken 1 stuk, Intraveneus |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per 3 weken 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_vrijetekstproduct_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.112: | Regel 11.203: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 14:52 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 11.122: | Regel 11.213: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="3"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ProductNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jemperli 500 mg/ 10 mL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 11.140: | Regel 11.235: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 11.154: | Regel 11.249: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 11.176: | Regel 11.271: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Telefoonnummer | |colspan="2"|Telefoonnummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1645645000 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 11.192: | Regel 11.287: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 11.205: | Regel 11.300: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-7-4-vrije-tekst-v30 /><section end=mv-mp-vo-tst-7-4-vrije-tekst-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 8 VV andermans MA== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /><section begin=patient-mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 11.225: | Regel 11.320: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 11.235: | Regel 11.330: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /><section begin=mbhs-mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /> |
| − | ==== Scenario | + | ==== Scenario 8.1 - MBH_300_VVandermansMA==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_VVandermansMA_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.259: | Regel 11.357: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 14 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 11.280: | Regel 11.378: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 11.293: | Regel 11.391: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|KopieIndicator | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_VVandermansMA_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.312: | Regel 11.413: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 11.322: | Regel 11.423: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|6 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 11.340: | Regel 11.441: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Marcha van Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Zorgaanbieder |
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /><section end=mv-mp-vo-tst-8-1-VV-onder-andermans-MA-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 8 Staken andermans MA== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /><section begin=patient-mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 11.425: | Regel 11.545: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 11.435: | Regel 11.555: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /><section begin=mbhs-mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /> |
| − | ==== Scenario | + | ==== Scenario 8.2 - MBH_300_stakenandermansMA==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_stakenandermansMA_MA2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.459: | Regel 11.582: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 5 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 11.477: | Regel 11.606: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geen indicatie voor medicamenteuze behandeling (code = '183966005' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 11.493: | Regel 11.625: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| − | |} | + | |}<section end=mbhs-mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /><section end=mv-mp-vo-tst-8-2-staken-andermans-MA-v30 /> |
| − | ==== | + | == TEST Scenarioset 8 Onderbreken andermans MA== |
| + | <section begin=mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /><section begin=patient-mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Meijs | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900808 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|26 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /><section begin=mbhs-mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /> | ||
| + | ==== Scenario 8.3 - MBH_300_stakenandermansMA==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_stakenandermansMA_MA2 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|RegistratieDatumTijd |
| + | |style="background-color: white;"|T om 09:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MedicatieafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geen indicatie voor medicamenteuze behandeling (code = '183966005' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Peter van Pulver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"|Werkadres: Dorpsstraat | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| − | |}<section end=mbhs-mv-mp-vo-tst- | + | |}<section end=mbhs-mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /><section end=mv-mp-vo-tst-8-3-onderbreken-andermans-MA-v30 /> |
| − | == TEST Scenarioset | + | == TEST Scenarioset 8 Wijzigen andermans MA== |
| − | <section begin=mv-mp-vo-tst- | + | <section begin=mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /><section begin=patient-mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 11.625: | Regel 11.839: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 11.635: | Regel 11.849: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst- | + | |}<section end=patient-mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /><section begin=mbhs-mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /> |
| − | ==== Scenario | + | ==== Scenario 8.4 - MBH_300_wijzigenandermansMA==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigenandermansMA_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.659: | Regel 11.876: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 1 dag |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 11.680: | Regel 11.900: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 11.693: | Regel 11.913: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_wijzigenandermansMA_MA2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.712: | Regel 11.939: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 09:10 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RedenWijzigenOfStaken |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="4"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Zorgaanbieder | |
| − | |||
| − | |||
| − | |||
| − | |colspan="4 | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
|style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |
| − | + | |}<section end=mbhs-mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /><section end=mv-mp-vo-tst-8-4-wijzigen-andermans-MA-v30 /> | |
| − | + | == TEST Scenarioset 9 Verbruiksperiode start/eind== | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | <section begin=mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /><section begin=patient-mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /> |
| − | |rowspan="4"| | + | {| class="wikitable" width="85%" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
| − | |colspan="4"| | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| − | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | + | |colspan="4" width="25%"| Gegevenselement |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | || Waarde |
| − | |colspan="4"| | + | |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="5"|Naamgegevens |
| − | |colspan="4"|Adresgegevens | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | + | |rowspan="6"| |
| − | |}<section end=mbhs-mv-mp-vo-tst-9- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Scenarioset 9 | + | |colspan="3"|Initialen |
| − | <section begin=mv-mp-vo-tst-9- | + | |style="background-color: white;"|M. |
| − | {| class="wikitable" width="85%" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | + | |colspan="3"|Naamgebruik |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |colspan="4" width="25%"| Gegevenselement | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | || Waarde | + | |colspan="4"|Geslachtsnaam |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |rowspan="2"| |
| − | |colspan="5"|Naamgegevens | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="2"|Achternaam |
| − | |rowspan="6"| | + | |style="background-color: white;"|XXX_Nederveen |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"|Initialen | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"|M. | + | |style="background-color: white;"|999900833 [BSN] |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"|Naamgebruik | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | + | |style="background-color: white;"|28 okt 1985 |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="4"|Geslachtsnaam | + | |colspan="4"|Geslacht |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |rowspan="2"| | + | |}<section end=patient-mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /><section begin=mbhs-mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /> |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | ==== Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind==== |
| − | |colspan="2"|Achternaam | + | |
| − | |style="background-color: white;"|XXX_Nederveen | + | {| class="wikitable" width="85%" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_logistiekeverbruiksperiode_start_eind_MA |
| − | |colspan="4"|Identificatienummer | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| − | |style="background-color: white;"|999900833 [BSN] | + | |colspan="3" width="25%"| Gegevenselement |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | || Waarde |
| − | |colspan="4"|Geboortedatum | + | |
| − | |style="background-color: white;"|28 okt 1985 | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="3"|Identificatie |
| − | |colspan="4"|Geslacht | + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |}<section end=patient-mv-mp-vo-tst-9- | + | |colspan="3"|RegistratieDatumTijd |
| − | ==== Scenario 9. | + | |style="background-color: white;"|T om 11:00 uur |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| − | {| class="wikitable" width="85%" | + | |colspan="3"|Gebruiksperiode |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 12 maanden'' |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3" width="25%"| Gegevenselement | + | |rowspan="3"| |
| − | || Waarde | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | + | |colspan="2"|Ingangsdatum | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: white;"|T |
| − | |colspan="3"|Identificatie | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: white;"| | + | |colspan="2"|Einddatum |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: white;"|T + 12 maanden |
| − | |colspan="3"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: white;"|T om | + | |colspan="4"|Voorschrijver |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"|Gebruiksperiode | + | |rowspan="2"| |
| − | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 13 | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="2"|Zorgverlener |
| − | |rowspan="3"| | + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="2"|Ingangsdatum | + | |colspan="3"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="2"|Einddatum | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"|T + 13 | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_start_eind_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksperiode | ||
| + | |style="background-color: white;"|Vanaf T, tot en met T + 12 maanden | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /><section end=mv-mp-vo-tst-9-1a-verbruiksperiode-start-eind-v30 /> | ||
| + | == TEST Scenarioset 9 Verbruiksperiode einddatum== | ||
| + | <section begin=mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /><section begin=patient-mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /><section begin=mbhs-mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /> | ||
| + | ==== Scenario 9.1b - MBH_300_distributievorm_GDS==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_distributievorm_GDS_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 11:01 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 200 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 200 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_distributievorm_GDS_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:01 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksperiode | ||
| + | |style="background-color: white;"|tot en met T + 200 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /><section end=mv-mp-vo-tst-9-1b-verbruiksperiode-einddatum-v30 /> | ||
| + | == TEST Scenarioset 9 Verbruiksperiode duur (dagen)== | ||
| + | <section begin=mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /><section begin=patient-mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /><section begin=mbhs-mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /> | ||
| + | ==== Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_logistiekeverbruiksperiode_duur_dagen_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 11:02 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 150 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_duur_dagen_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:02 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksperiode | ||
| + | |style="background-color: white;"|gedurende 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /><section end=mv-mp-vo-tst-9-1c-verbruiksperiode-duur-v30 /> | ||
| + | == TEST Scenarioset 9 Herhalingen== | ||
| + | <section begin=mv-mp-vo-tst-9-2-herhalingen-v30 /><section begin=patient-mv-mp-vo-tst-9-2-herhalingen-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-2-herhalingen-v30 /><section begin=mbhs-mv-mp-vo-tst-9-2-herhalingen-v30 /> | ||
| + | ==== Scenario 9.2 - MBH_300_herhalingen==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_herhalingen_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 11:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_herhalingen_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AantalHerhalingen | ||
| + | |style="background-color: white;"|5 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-2-herhalingen-v30 /><section end=mv-mp-vo-tst-9-2-herhalingen-v30 /> | ||
| + | == TEST Scenarioset 9 Afleverlocatie== | ||
| + | <section begin=mv-mp-vo-tst-9-3-afleverlocatie-v30 /><section begin=patient-mv-mp-vo-tst-9-3-afleverlocatie-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-3-afleverlocatie-v30 /><section begin=mbhs-mv-mp-vo-tst-9-3-afleverlocatie-v30 /> | ||
| + | ==== Scenario 9.3 - MBH_300_afleverlocatie==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_afleverlocatie_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 11:07 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T + 1 dag | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|3 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_afleverlocatie_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:07 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Afleverlocatie | ||
| + | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-3-afleverlocatie-v30 /><section end=mv-mp-vo-tst-9-3-afleverlocatie-v30 /> | ||
| + | == TEST Scenarioset 9 Financiele indicatiecode== | ||
| + | <section begin=mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /><section begin=patient-mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /><section begin=mbhs-mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /> | ||
| + | ==== Scenario 9.4 - MBH_300_financiele_indicatiecode==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_financiele_indicatiecode_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 11:35 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 13 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 13 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|4 maal per dag 1 stuk, oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|4 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_financiele_indicatiecode_VV | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_financiele_indicatiecode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekkingsverzoekDatumTijd | ||
| + | |style="background-color: white;"|T om 11:35 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|TeVerstrekkenHoeveelheid | ||
| + | |style="background-color: white;"|56 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|BeoogdVerstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|FinanciëleIndicatiecode | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): B2 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieMedicatieafspraak | ||
| + | |style="background-color: white;"|MBH_300_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="13"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Naamgegevens | ||
| + | |style="background-color: white;"|Bertine van Doorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Contactgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Telefoonnummers | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Telefoonnummer | ||
| + | |style="background-color: white;"|1634534000 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|NummerSoort | ||
| + | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /><section end=mv-mp-vo-tst-9-4-financiele-indicatiecode-v30 /> | ||
| + | == TEST Scenarioset 9 geannuleerd indicator start== | ||
| + | <section begin=mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /><section begin=patient-mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Nederveen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900833 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|28 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /><section begin=mbhs-mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /> | ||
| + | ==== Scenario 9.5a - MBH_300_geannuleerd_indicator==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_geannuleerd_indicator_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 13:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T om 13:00 uur, tot en met T + 180 dagen om 13:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T om 13:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 180 dagen om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Voorschrijver | |colspan="4"|Voorschrijver | ||
| Regel 11.883: | Regel 13.304: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 11.896: | Regel 13.317: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 11.902: | Regel 13.323: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_300_geannuleerd_indicator_VV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 11.915: | Regel 13.336: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_indicator_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Auteur | |colspan="4"|Auteur | ||
| Regel 11.925: | Regel 13.346: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgverlener | |colspan="2"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|180 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 11.943: | Regel 13.364: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 11.960: | Regel 13.378: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="6"|<span id=" | + | |colspan="6"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 11.984: | Regel 13.402: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 11.998: | Regel 13.416: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.011: | Regel 13.429: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-9- | + | |}<section end=mbhs-mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /><section end=mv-mp-vo-tst-9-5a-geannuleerd-indicator-v30 /> |
| − | == TEST Scenarioset 9 geannuleerd indicator== | + | == TEST Scenarioset 9 geannuleerd indicator annulering== |
| − | <section begin=mv-mp-vo-tst-9- | + | <section begin=mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /><section begin=patient-mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 12.054: | Regel 13.472: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mv-mp-vo-tst-9- | + | |}<section end=patient-mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /><section begin=mbhs-mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /> |
| − | ==== Scenario 9. | + | ==== Scenario 9.5b - MBH_300_geannuleerd_indicator==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| Regel 12.067: | Regel 13.485: | ||
|style="background-color: white;"|MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.120: | Regel 13.538: | ||
|style="background-color: white;"|MBH_300_geannuleerd_indicator_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_geannuleerd_indicator_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|GeannuleerdIndicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.133: | Regel 13.551: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|180 stuks | |style="background-color: white;"|180 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.142: | Regel 13.560: | ||
|style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.149: | Regel 13.567: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_geannuleerd_indicator_MA | + | |style="background-color: white;"|MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 12.167: | Regel 13.585: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 12.187: | Regel 13.605: | ||
|style="background-color: white;"|1634534000 | |style="background-color: white;"|1634534000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.201: | Regel 13.619: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.214: | Regel 13.632: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Adresgegevens | |colspan="4"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| − | |}<section end=mbhs-mv-mp-vo-tst-9- | + | |}<section end=mbhs-mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /><section end=mv-mp-vo-tst-9-5b-geannuleerd-indicator-v30 /> |
== TEST Scenarioset 10 HPK== | == TEST Scenarioset 10 HPK== | ||
<section begin=mv-mp-vo-tst-10-1-hpk-v30 /><section begin=patient-mv-mp-vo-tst-10-1-hpk-v30 /> | <section begin=mv-mp-vo-tst-10-1-hpk-v30 /><section begin=patient-mv-mp-vo-tst-10-1-hpk-v30 /> | ||
| Regel 12.270: | Regel 13.688: | ||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.326: | Regel 13.744: | ||
|style="background-color: white;"|MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.336: | Regel 13.754: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|150 stuks | |style="background-color: white;"|150 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.348: | Regel 13.766: | ||
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.355: | Regel 13.773: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_HPKvoorschrijven_MA | + | |style="background-color: white;"|MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 12.373: | Regel 13.791: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 12.393: | Regel 13.811: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.407: | Regel 13.825: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.420: | Regel 13.838: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.476: | Regel 13.894: | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.498: | Regel 13.916: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 12.535: | Regel 13.953: | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.545: | Regel 13.963: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|150 stuks | |style="background-color: white;"|150 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 12.560: | Regel 13.978: | ||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.567: | Regel 13.985: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 12.585: | Regel 14.003: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 12.605: | Regel 14.023: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.619: | Regel 14.037: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.632: | Regel 14.050: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.688: | Regel 14.106: | ||
|style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 08:00 uur | |style="background-color: white;"|T om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.722: | Regel 14.140: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.738: | Regel 14.156: | ||
|style="background-color: white;"|MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 08:00 uur | |style="background-color: white;"|T om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.748: | Regel 14.166: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.757: | Regel 14.175: | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.764: | Regel 14.182: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_wdsmtd1_MA | + | |style="background-color: white;"|MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 12.782: | Regel 14.200: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 12.802: | Regel 14.220: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.816: | Regel 14.234: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.829: | Regel 14.247: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.885: | Regel 14.303: | ||
|style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 08:00 uur | |style="background-color: white;"|T om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.922: | Regel 14.340: | ||
|style="background-color: white;"|1 maal per dag 2 stuks | |style="background-color: white;"|1 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieContact |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.929: | Regel 14.347: | ||
|style="background-color: white;"|MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | |style="background-color: white;"|MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieZorgepisode |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.949: | Regel 14.367: | ||
|style="background-color: white;"|MBH_300_contactepisode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |style="background-color: white;"|MBH_300_contactepisode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekkingsverzoekDatumTijd |
|style="background-color: white;"|T om 08:00 uur | |style="background-color: white;"|T om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.959: | Regel 14.377: | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|TeVerstrekkenHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 12.968: | Regel 14.386: | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|BeoogdVerstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 12.975: | Regel 14.393: | ||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieMedicatieafspraak |
| − | |style="background-color: white;"|MBH_300_contactepisode_MA | + | |style="background-color: white;"|MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| Regel 12.993: | Regel 14.411: | ||
|rowspan="13"| | |rowspan="13"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Naamgegevens | |colspan="4"|Naamgegevens | ||
| − | |style="background-color: white;"|Peter van | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Specialisme | |colspan="4"|Specialisme | ||
| Regel 13.013: | Regel 14.431: | ||
|style="background-color: white;"|1645645000 | |style="background-color: white;"|1645645000 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|NummerSoort |
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 13.027: | Regel 14.445: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 13.040: | Regel 14.458: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
Huidige versie van 12 dec 2025 om 12:10
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend systeem
- 1.3 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en einddatum
- 1.4 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en duur (weken)
- 1.5 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en duur (dagen)
- 1.6 TEST Scenarioset 1 Chronische medicatie
- 1.7 TEST Scenarioset 1 Extra VV onder bestaande MA
- 1.8 TEST Scenarioset 1 MA met eenheid 'dosis/stuks'
- 1.9 TEST Scenarioset 1 MA met onzekerheidscriterium
- 1.10 TEST Scenarioset 2 Aanvullende Instructie
- 1.11 TEST Scenarioset 2 Toelichting
- 1.12 TEST Scenarioset 2 Reden van voorschrijven
- 1.13 TEST Scenarioset 2 Aanvullende informatie en wensen
- 1.14 TEST Scenarioset 2 Toedieningsweg
- 1.15 TEST Scenarioset 3 (initieren scenario) Stoppen
- 1.16 TEST Scenarioset 3 Stoppen
- 1.17 TEST Scenarioset 3 (initieren scenario) Wijzigen MA (verhoging)
- 1.18 TEST Scenarioset 3 Wijzigen (verhoging)
- 1.19 TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)
- 1.20 TEST Scenarioset 3 Wijzigen (verlaging)
- 1.21 TEST Scenarioset 3 (initieren scenario) Onderbreken
- 1.22 TEST Scenarioset 3 Onderbreken
- 1.23 TEST Scenarioset 3 TA wijzigen (onveranderde MA)
- 1.24 TEST Scenarioset 3 (initieren scenario) annuleren
- 1.25 TEST Scenarioset 3 annuleren
- 1.26 TEST Scenarioset 3 (initieren scenario) VolgendeBehandelaar
- 1.27 TEST Scenarioset 3 (stoppen scenario) VolgendeBehandelaar
- 1.28 TEST Scenarioset 3 VolgendeBehandelaar
- 1.29 TEST Scenarioset 3 Stoppen parallelle TA (onveranderde MA)
- 1.30 TEST Scenarioset 4 Lengte Gewicht
- 1.31 TEST Scenarioset 4 Lengte gewicht persistent
- 1.32 TEST Scenarioset 4 Nierfunctie NHG
- 1.33 TEST Scenarioset 4 Nierfunctie Loinc zonder panel
- 1.34 TEST Scenarioset 6 Variabele frequentie
- 1.35 TEST Scenarioset 6 Interval
- 1.36 TEST Scenarioset 6 Variabele hoeveelheid
- 1.37 TEST Scenarioset 6 Zonder keerdosis
- 1.38 TEST Scenarioset 6 Bijzondere keerdosis
- 1.39 TEST Scenarioset 6 Variabele hoeveelheid 2
- 1.40 TEST Scenarioset 6 Tijdstippen flexibel
- 1.41 TEST Scenarioset 6 Tijdstippen niet flexibel
- 1.42 TEST Scenarioset 6 Weekdagen
- 1.43 TEST Scenarioset 6 Dagdeel
- 1.44 TEST Scenarioset 6 Cyclisch schema
- 1.45 TEST Scenarioset 6 Afbouwschema
- 1.46 TEST Scenarioset 6 Variabele hoeveelheid en maximum
- 1.47 TEST Scenarioset 6 Toedieningssnelheid
- 1.48 TEST Scenarioset 6 Toedieningsduur
- 1.49 TEST Scenarioset 6 Zo nodig
- 1.50 TEST Scenarioset 6 Trombosedienst
- 1.51 TEST Scenarioset 6 redundante frequentie
- 1.52 TEST Scenarioset 7 Alle ingrediënten
- 1.53 TEST Scenarioset 7 Actief ingrediënt
- 1.54 TEST Scenarioset 7 90 miljoen nummer
- 1.55 TEST Scenarioset 7 vrije tekst product
- 1.56 TEST Scenarioset 8 VV andermans MA
- 1.57 TEST Scenarioset 8 Staken andermans MA
- 1.58 TEST Scenarioset 8 Onderbreken andermans MA
- 1.59 TEST Scenarioset 8 Wijzigen andermans MA
- 1.60 TEST Scenarioset 9 Verbruiksperiode start/eind
- 1.61 TEST Scenarioset 9 Verbruiksperiode einddatum
- 1.62 TEST Scenarioset 9 Verbruiksperiode duur (dagen)
- 1.63 TEST Scenarioset 9 Herhalingen
- 1.64 TEST Scenarioset 9 Afleverlocatie
- 1.65 TEST Scenarioset 9 Financiele indicatiecode
- 1.66 TEST Scenarioset 9 geannuleerd indicator start
- 1.67 TEST Scenarioset 9 geannuleerd indicator annulering
- 1.68 TEST Scenarioset 10 HPK
- 1.69 TEST Scenarioset 10 ZI-nummer
- 1.70 TEST Scenarioset 11 extern doseerschema
- 1.71 TEST Scenarioset 13.1 relatie contact episode
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset 1
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 1.1* | Maak screenshot(s) waarop zichtbaar is dat gebruiksperiode kan worden ingevoerd | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum |
MBH_300_start_eind | MBH_300_start_eind_MA | MBH_300_start_eind_VV |
| 1.2a* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken) |
MBH_300_start_duur | MBH_300_start_duur_MA | MBH_300_start_duur_VV |
| 1.2b* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen) |
MBH_300_start_duur2 | MBH_300_start_duur2_MA | MBH_300_start_duur2_VV |
| 1.3 | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie) |
MBH_300_chronisch | MBH_300_chronisch_MA | MBH_300_chronisch_VV | |
| 1.4 | Maak screenshot(s) waaruit blijkt dat het extra VV gemaakt wordt/behoort bij de eerdere MA. | Extra VV onder bestaande MA LET OP: VV bij de bestaande MA uit scenario 1.3 (20 dagen later) |
MBH_300_chronisch | MBH_300_chronisch_MA | MBH_300_chronisch_VV_extraVVbestaandeMA |
| 1.5 | Medicatievoorschrift met eenheid 'dosis/stuks' |
MBH_300_dosis_stuks | MBH_300_dosis_stuks_MA | MBH_300_dosis_stuks_VV | |
| 1.6 | Medicatievoorschrift met onzekerheidscriterium |
MBH_300_start_criterium | MBH_300_start_criterium_MA | MBH_300_start_criterium_VV |
1.1.2 Scenarioset 2
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 2.1 | Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje) | Aanvullende instructie (MA) |
MBH_300_aanvullendeinstructie | MBH_300_aanvullendeinstructie_MA | MBH_300_aanvullendeinstructie_VV |
| 2.2 | Maak screenshot(s) waaruit blijkt dat bij zowel de MA als VV een 'toelichting' ingevoerd kan worden | Toelichting (MA), toelichting (VV) |
MBH_300_toelichting | MBH_300_toelichting_MA | MBH_300_toelichting_VV |
| 2.3 | Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld. | Reden van voorschrijven (MA) |
MBH_300_redenvanvoorschrijven | MBH_300_redenvanvoorschrijven_MA | MBH_300_redenvanvoorschrijven_VV |
| 2.4 | Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (MA) en 'aanvullende wensen' (VV) zichtbaar zijn | Aanvullende informatie (MA), aanvullende wensen (VV) |
MBH_300_aanvullendeinformatiewensen | MBH_300_aanvullendeinformatiewensen_MA | MBH_300_aanvullendeinformatiewensen_VV |
| 2.5 | Maak screenshot(s) waarop toedieningsweg keuze zichtbaar is. Deze wijkt af t.o.v. de standaard toedieningsweg van het geneesmiddel. | Toedieningsweg (MA) |
MBH_300_Toedieningsweg | MBH_300_Toedieningsweg_MA | MBH_300_Toedieningsweg_VV |
1.1.3 Scenarioset 3
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 3.1a | Benodigd voor scenario 3.1b |
MBH_300_stoppen | MBH_300_stoppen_MA_start | MBH_300_stoppen_VV | |
| 3.1b | Stop-medicatieafspraak, met reden staken LET OP: stoppen medicatieafspraak van scenario 3.1a |
MBH_300_stoppen | MBH_300_stoppen_MA_staken | ||
| 3.2a | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Benodigd voor scenario 3.2b |
MBH_300_wijzigen_verhoging | MBH_300_wijzigen_verhoging_MA_start | MBH_300_wijzigen_verhoging_VV |
| 3.2b | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV LET OP: wijziging medicatieafspraak van scenario 3.2a |
MBH_300_wijzigen_verhoging | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV MBH_300_wijzigen_verhoging_MA_techstaken |
MBH_300_wijzigen_verhoging_VV_extra |
| 3.3a | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Benodigd voor scenario 3.3b |
MBH_300_wijzigen_verlaging | MBH_300_wijzigen_verlaging_MA_start | MBH_300_wijzigen_verlaging_VV |
| 3.3b | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV LET OP: wijziging medicatieafspraak van scenario 3.3a |
MBH_300_wijzigen_verlaging | MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV MBH_300_wijzigen_verlaging_MA_techstaken |
|
| 3.4a | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Benodigd voor scenario 3.4b |
MBH_300_onderbreken | MBH_300_onderbreken_MA_start | MBH_300_onderbreken_VV |
| 3.4b | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onderbreken medicatieafspraak LET OP: onderbreking medicatieafspraak van scenario 3.4a |
MBH_300_onderbreken | MBH_300_onderbreken_MA_onderbreken | |
| 3.5 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onveranderde medicatieafspraak met wijziging toedieningsafspraak |
MBH_300_TAwijzigen | MBH_300_TAwijzigen_MA | MBH_300_TAwijzigen_VV |
| 3.6a | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Benodigd voor scenario 3.6b |
MBH_300_annuleren | MBH_300_annuleren_MA_starten | MBH_300_annuleren_VV_starten |
| 3.6b | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Annuleer-medicatieafspraak, met reden staken LET OP: stoppen medicatieafspraak van scenario 3.6a |
MBH_300_annuleren | MBH_300_annuleren_MA_geannuleerd | |
| 3.7a | Benodigd voor scenario 3.7b |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Start1 | MBH_300_VolgendeBehandelaar_VV_Start1 | |
| 3.7b | Maak screenshot(s) waarin het veld 'VolgendeBehandelaar' zichtbaar is | Stop-medicatieafspraak LET OP: tijdelijk stoppen van medicatieafspraak van scenario 3.7a |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Stop1 | |
| 3.7c | Medicatieafspraak met VolgendeBehandelaar gevuld LET OP: Hiermee wordt de MA van scenarioset 3.7a weer "hervat". Als in het beleid van MA 3.7a wordt weer voortgezet met de MA van 3.7c |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Start2 | MBH_300_VolgendeBehandelaar_VV_Start2 | |
| 3.8 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onveranderde medicatieafspraak met wijziging in één van de toedieningsafspraken |
MBH_300_stoppen_parallele_TA | MBH_300_stoppen_parallele_TA_MA_start | MBH_300_stoppen_parallele_TA_VV_start |
1.1.4 Scenarioset 4
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 4.1a | Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden | Medicatievoorschrift, met lengte en gewicht |
MBH_300_VOS_Lengte_Gewicht | MBH_300_VOS_Lengte_Gewicht_MA | MBH_300_VOS_Lengte_Gewicht_VV |
| 4.1b | Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden | Medicatievoorschrift, met lengte en gewicht (persistent) |
MBH_300_VOS_Lengte_Gewicht | MBH_300_VOS_Lengte_Gewicht_MA | MBH_300_VOS_Lengte_Gewicht_VV |
| 4.2a | Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat | Medicatievoorschrift, met test op labuitwisseling met NHG codes |
MBH_300_VOS_Lab | MBH_300_VOS_Lab_MA | MBH_300_VOS_Lab_VV |
| 4.2b | Maak screenshot(s) waarin zichtbaar is dat er ook een nierfunctie bij deze patiënt bestaat | Medicatievoorschrift, met test op labuitwisseling met LOINC codes |
MBH_300_VOS_Lab | MBH_300_VOS_Lab_MA | MBH_300_VOS_Lab_VV |
1.1.5 Scenarioset 6
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 6.1 | Variabele frequentie |
MBH_300_variabelefrequentie | MBH_300_variabelefrequentie_MA | MBH_300_variabelefrequentie_VV | |
| 6.2 | Interval |
MBH_300_interval | MBH_300_interval_MA | MBH_300_interval_VV | |
| 6.3 | Variabele hoeveelheid (1) |
MBH_300_variabelehoeveelheid | MBH_300_variabelehoeveelheid_MA | MBH_300_variabelehoeveelheid_VV | |
| 6.4 | Zonder keerdosis |
MBH_300_zonderkeerdosis | MBH_300_zonderkeerdosis_MA | MBH_300_zonderkeerdosis_VV | |
| 6.5 | Bijzondere keerdosis |
MBH_300_bijzonderekeerdosis | MBH_300_bijzonderekeerdosis_MA | MBH_300_bijzonderekeerdosis_VV | |
| 6.6 | Variabele hoeveelheid (2) |
MBH_300_variabelehoeveelheid2 | MBH_300_variabelehoeveelheid2_MA | MBH_300_variabelehoeveelheid2_VV | |
| 6.7a | Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden | Tijdstippen |
MBH_300_tijdstippen_flexibel | MBH_300_tijdstippen_flexibel_MA | MBH_300_tijdstippen_flexibel_VV |
| 6.7b | Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden | Tijdstippen |
MBH_300_tijdstippen_niet_flexibel | MBH_300_tijdstippen_niet_flexibel_MA | MBH_300_tijdstippen_niet_flexibel_VV |
| 6.8 | Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden | Weekdagen |
MBH_300_weekdagen | MBH_300_weekdagen_MA | MBH_300_weekdagen_VV |
| 6.9 | Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden | Dagdeel |
MBH_300_dagdeel | MBH_300_dagdeel_MA | MBH_300_dagdeel_VV |
| 6.10 | Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden | Cyclisch schema |
MBH_300_cyclischschema | MBH_300_cyclischschema_MA | MBH_300_cyclischschema_VV |
| 6.11 | Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden | Afbouw schema en doseerduur |
MBH_300_afbouwschema | MBH_300_afbouwschema_MA | MBH_300_afbouwschema_VV |
| 6.12 | Variabele hoeveelheid en maximum |
MBH_300_variabelehoeveelheidenmaximum | MBH_300_variabelehoeveelheidenmaximum_MA | MBH_300_variabelehoeveelheidenmaximum_VV | |
| 6.13 | Toedieningssnelheid |
MBH_300_toedieningssnelheid | MBH_300_toedieningssnelheid_MA | MBH_300_toedieningssnelheid_VV | |
| 6.14 | Toedieningsduur |
MBH_300_toedieningsduur | MBH_300_toedieningsduur_MA | MBH_300_toedieningsduur_VV | |
| 6.15 | Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid) | Zo nodig |
MBH_300_zonodig | MBH_300_zonodig_MA | MBH_300_zonodig_VV |
| 6.16 | Deze test is optioneel en alleen bedoeld voor de trombosedienstsystemen. | Dagdeel |
MBH_300_WDS_trombose_medicatie | MBH_300_WDS_trombose_medicatie_MA | MBH_300_WDS_trombose_medicatie_VV |
| 6.17 | Maak screenshot(s) waarop zichtbaar is dat de frequentie i.c.m. toedientijden ingevuld kan worden | Redundante frequentie |
MBH_300_redundantefrequentie | MBH_300_redundantefrequentie_MA | MBH_300_redundantefrequentie_VV |
1.1.6 Scenarioset 7
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten |
MBH_300_magistraalalleingredienten | MBH_300_magistraalalleingredienten_MA | MBH_300_magistraalalleingredienten_VV |
| 7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt |
MBH_300_magistraalactieveingredient | MBH_300_magistraalactieveingredient_MA | MBH_300_magistraalactieveingredient_VV |
| 7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt | 90 miljoen nummer |
MBH_300_magistraal90miljoennr | MBH_300_magistraal90miljoennr_MA | MBH_300_magistraal90miljoennr_VV |
| 7.4 | Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt | Vrije tekst product |
MBH_300_vrijetekstproduct | MBH_300_vrijetekstproduct_MA | MBH_300_vrijetekstproduct_VV |
1.1.7 Scenarioset 8
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 8.1 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Verstrekkingsverzoek onder andermans medicatieafspraak |
MBH_300_VVandermansMA | MBH_300_VVandermansMA_MA | MBH_300_VVandermansMA_VV |
| 8.2 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Stoppen andermans medicatieafspraak |
MBH_300_stakenandermansMA | MBH_300_stakenandermansMA_MA2 | |
| 8.3 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onderbreken andermans medicatieafspraak |
MBH_300_stakenandermansMA | MBH_300_stakenandermansMA_MA2 | |
| 8.4 | Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijzigen andermans medicatieafspraak |
MBH_300_wijzigenandermansMA | MBH_300_wijzigenandermansMA_MA_techstaken MBH_300_wijzigenandermansMA_MA2 |
1.1.8 Scenarioset 9
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 9.1a | Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum) | Logistieke verbruiksperiode |
MBH_300_logistiekeverbruiksperiode_start_eind | MBH_300_logistiekeverbruiksperiode_start_eind_MA | MBH_300_logistiekeverbruiksperiode_start_eind_VV |
| 9.1b | Logistieke verbruiksperiode |
MBH_300_distributievorm_GDS | MBH_300_distributievorm_GDS_MA | MBH_300_distributievorm_GDS_VV | |
| 9.1c | Logistieke verbruiksperiode |
MBH_300_logistiekeverbruiksperiode_duur_dagen | MBH_300_logistiekeverbruiksperiode_duur_dagen_MA | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV | |
| 9.2 | Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden | Herhalingen |
MBH_300_herhalingen | MBH_300_herhalingen_MA | MBH_300_herhalingen_VV |
| 9.3 | Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden | Afleverlocatie |
MBH_300_afleverlocatie | MBH_300_afleverlocatie_MA | MBH_300_afleverlocatie_VV |
| 9.4 | Maak screenshot(s) waarop zichtbaar is dat een financiële indicatiecode ingevoerd/gekozen kan worden | Financiële indicatiecode |
MBH_300_financiele_indicatiecode | MBH_300_financiele_indicatiecode_MA | MBH_300_financiele_indicatiecode_VV |
| 9.5a | Maak screenshot(s) waarop zichtbaar is dat een geannuleerd indicator ingevoerd/gekozen kan worden | Geannuleerd indicator |
MBH_300_geannuleerd_indicator | MBH_300_geannuleerd_indicator_MA | MBH_300_geannuleerd_indicator_VV |
| 9.5b | Maak screenshot(s) waarop zichtbaar is dat een geannuleerd indicator ingevoerd/gekozen kan worden | Geannuleerd indicator |
MBH_300_geannuleerd_indicator | MBH_300_geannuleerd_indicator_MA | MBH_300_geannuleerd_indicator_VV |
1.1.9 Scenarioset 10
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 10.1 | HPK geneesmiddel |
MBH_300_HPKvoorschrijven | MBH_300_HPKvoorschrijven_MA | MBH_300_HPKvoorschrijven_VV | |
| 10.2 | ZI-nr geneesmiddel |
MBH_300_ZINRvoorschrijven | MBH_300_ZINRvoorschrijven_MA | MBH_300_ZINRvoorschrijven_VV |
1.1.10 Scenarioset 11
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 11.1 | Maak screenshot(s) waarop zichtbaar is dat er verwezen kan worden naar een extern dosseerschema. | Medicatievoorschrift met een medicatieafspraak verwijzend naar extern doseerschema |
MBH_300_wdsmtd1 | MBH_300_wdsmtd1_MA | MBH_300_wdsmtd1_VV |
1.1.11 Scenarioset 13
| Scenario | Screenshots? | Beschrijving | MBH id | MA id | VV id |
| 13.1 | Relatie naar patiëntcontact en zorgepisode |
MBH_300_contactepisode | MBH_300_contactepisode_MA | MBH_300_contactepisode_VV |
1.2 Overzicht van scenario's voor ontvangend systeem
1.2.1 Scenarioset 1
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 1.1 | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum |
MBH_300_start_eind | MBH_300_start_eind_MA | MBH_300_start_eind_VV |
| 1.2a | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken) |
MBH_300_start_duur | MBH_300_start_duur_MA | MBH_300_start_duur_VV |
| 1.2b | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen) |
MBH_300_start_duur2 | MBH_300_start_duur2_MA | MBH_300_start_duur2_VV |
| 1.3 | Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie) |
MBH_300_chronisch | MBH_300_chronisch_MA | MBH_300_chronisch_VV |
| 1.4 | Extra VV onder bestaande MA LET OP: VV bij de bestaande MA uit scenario 1.3 (20 dagen later) |
MBH_300_chronisch | MBH_300_chronisch_MA | MBH_300_chronisch_VV_extraVVbestaandeMA |
| 1.5 | Medicatievoorschrift met eenheid 'dosis/stuks' |
MBH_300_dosis_stuks | MBH_300_dosis_stuks_MA | MBH_300_dosis_stuks_VV |
| 1.6 | Medicatievoorschrift met onzekerheidscriterium |
MBH_300_start_criterium | MBH_300_start_criterium_MA | MBH_300_start_criterium_VV |
1.2.2 Scenarioset 2
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 2.1 | Aanvullende instructie (MA) |
MBH_300_aanvullendeinstructie | MBH_300_aanvullendeinstructie_MA | MBH_300_aanvullendeinstructie_VV |
| 2.2 | Toelichting (MA), toelichting (VV) |
MBH_300_toelichting | MBH_300_toelichting_MA | MBH_300_toelichting_VV |
| 2.3 | Reden van voorschrijven (MA) |
MBH_300_redenvanvoorschrijven | MBH_300_redenvanvoorschrijven_MA | MBH_300_redenvanvoorschrijven_VV |
| 2.4 | Aanvullende informatie (MA), aanvullende wensen (VV) |
MBH_300_aanvullendeinformatiewensen | MBH_300_aanvullendeinformatiewensen_MA | MBH_300_aanvullendeinformatiewensen_VV |
| 2.5 | Toedieningsweg (MA) |
MBH_300_Toedieningsweg | MBH_300_Toedieningsweg_MA | MBH_300_Toedieningsweg_VV |
1.2.3 Scenarioset 3
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 3.1a | Benodigd voor scenario 3.1b |
MBH_300_stoppen | MBH_300_stoppen_MA_start | MBH_300_stoppen_VV |
| 3.1b | Stop-medicatieafspraak, met reden staken LET OP: stoppen medicatieafspraak van scenario 3.1a |
MBH_300_stoppen | MBH_300_stoppen_MA_staken | |
| 3.2a | Benodigd voor scenario 3.2b |
MBH_300_wijzigen_verhoging | MBH_300_wijzigen_verhoging_MA_start | MBH_300_wijzigen_verhoging_VV |
| 3.2b | Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV LET OP: wijziging medicatieafspraak van scenario 3.2a |
MBH_300_wijzigen_verhoging | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV MBH_300_wijzigen_verhoging_MA_techstaken |
MBH_300_wijzigen_verhoging_VV_extra |
| 3.3a | Benodigd voor scenario 3.3b |
MBH_300_wijzigen_verlaging | MBH_300_wijzigen_verlaging_MA_start | MBH_300_wijzigen_verlaging_VV |
| 3.3b | Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV LET OP: wijziging medicatieafspraak van scenario 3.3a |
MBH_300_wijzigen_verlaging | MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV MBH_300_wijzigen_verlaging_MA_techstaken |
|
| 3.4a | Benodigd voor scenario 3.4b |
MBH_300_onderbreken | MBH_300_onderbreken_MA_start | MBH_300_onderbreken_VV |
| 3.4b | Onderbreken medicatieafspraak LET OP: onderbreking medicatieafspraak van scenario 3.4a |
MBH_300_onderbreken | MBH_300_onderbreken_MA_onderbreken | |
| 3.5 | Onveranderde medicatieafspraak met wijziging toedieningsafspraak |
MBH_300_TAwijzigen | MBH_300_TAwijzigen_MA | MBH_300_TAwijzigen_VV |
| 3.6a | Benodigd voor scenario 3.6b |
MBH_300_annuleren | MBH_300_annuleren_MA_starten | MBH_300_annuleren_VV_starten |
| 3.6b | Annuleer-medicatieafspraak, met reden staken LET OP: stoppen medicatieafspraak van scenario 3.6a |
MBH_300_annuleren | MBH_300_annuleren_MA_geannuleerd | |
| 3.7a | Benodigd voor scenario 3.7b |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Start1 | MBH_300_VolgendeBehandelaar_VV_Start1 |
| 3.7b | Stop-medicatieafspraak LET OP: tijdelijk stoppen van medicatieafspraak van scenario 3.7a |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Stop1 | |
| 3.7c | Medicatieafspraak met VolgendeBehandelaar gevuld LET OP: Hiermee wordt de MA van scenarioset 3.7a weer "hervat". Als in het beleid van MA 3.7a wordt weer voortgezet met de MA van 3.7c |
MBH_300_VolgendeBehandelaar | MBH_300_VolgendeBehandelaar_MA_Start2 | MBH_300_VolgendeBehandelaar_VV_Start2 |
| 3.8 | Onveranderde medicatieafspraak met wijziging in één van de toedieningsafspraken |
MBH_300_stoppen_parallele_TA | MBH_300_stoppen_parallele_TA_MA_start | MBH_300_stoppen_parallele_TA_VV_start |
1.2.4 Scenarioset 4
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 4.1a | Medicatievoorschrift, met lengte en gewicht |
MBH_300_VOS_Lengte_Gewicht | MBH_300_VOS_Lengte_Gewicht_MA | MBH_300_VOS_Lengte_Gewicht_VV |
| 4.1b | Medicatievoorschrift, met lengte en gewicht (persistent) |
MBH_300_VOS_Lengte_Gewicht | MBH_300_VOS_Lengte_Gewicht_MA | MBH_300_VOS_Lengte_Gewicht_VV |
| 4.2a | Medicatievoorschrift, met test op labuitwisseling met NHG codes |
MBH_300_VOS_Lab | MBH_300_VOS_Lab_MA | MBH_300_VOS_Lab_VV |
| 4.2b | Medicatievoorschrift, met test op labuitwisseling met LOINC codes |
MBH_300_VOS_Lab | MBH_300_VOS_Lab_MA | MBH_300_VOS_Lab_VV |
1.2.5 Scenarioset 6
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 6.1 | Variabele frequentie |
MBH_300_variabelefrequentie | MBH_300_variabelefrequentie_MA | MBH_300_variabelefrequentie_VV |
| 6.2 | Interval |
MBH_300_interval | MBH_300_interval_MA | MBH_300_interval_VV |
| 6.3 | Variabele hoeveelheid (1) |
MBH_300_variabelehoeveelheid | MBH_300_variabelehoeveelheid_MA | MBH_300_variabelehoeveelheid_VV |
| 6.4 | Zonder keerdosis |
MBH_300_zonderkeerdosis | MBH_300_zonderkeerdosis_MA | MBH_300_zonderkeerdosis_VV |
| 6.5 | Bijzondere keerdosis |
MBH_300_bijzonderekeerdosis | MBH_300_bijzonderekeerdosis_MA | MBH_300_bijzonderekeerdosis_VV |
| 6.6 | Variabele hoeveelheid (2) |
MBH_300_variabelehoeveelheid2 | MBH_300_variabelehoeveelheid2_MA | MBH_300_variabelehoeveelheid2_VV |
| 6.7a | Tijdstippen |
MBH_300_tijdstippen_flexibel | MBH_300_tijdstippen_flexibel_MA | MBH_300_tijdstippen_flexibel_VV |
| 6.7b | Tijdstippen |
MBH_300_tijdstippen_niet_flexibel | MBH_300_tijdstippen_niet_flexibel_MA | MBH_300_tijdstippen_niet_flexibel_VV |
| 6.8 | Weekdagen |
MBH_300_weekdagen | MBH_300_weekdagen_MA | MBH_300_weekdagen_VV |
| 6.9 | Dagdeel |
MBH_300_dagdeel | MBH_300_dagdeel_MA | MBH_300_dagdeel_VV |
| 6.10 | Cyclisch schema |
MBH_300_cyclischschema | MBH_300_cyclischschema_MA | MBH_300_cyclischschema_VV |
| 6.11 | Afbouw schema en doseerduur |
MBH_300_afbouwschema | MBH_300_afbouwschema_MA | MBH_300_afbouwschema_VV |
| 6.12 | Variabele hoeveelheid en maximum |
MBH_300_variabelehoeveelheidenmaximum | MBH_300_variabelehoeveelheidenmaximum_MA | MBH_300_variabelehoeveelheidenmaximum_VV |
| 6.13 | Toedieningssnelheid |
MBH_300_toedieningssnelheid | MBH_300_toedieningssnelheid_MA | MBH_300_toedieningssnelheid_VV |
| 6.14 | Toedieningsduur |
MBH_300_toedieningsduur | MBH_300_toedieningsduur_MA | MBH_300_toedieningsduur_VV |
| 6.15 | Zo nodig |
MBH_300_zonodig | MBH_300_zonodig_MA | MBH_300_zonodig_VV |
| 6.16 | Dagdeel |
MBH_300_WDS_trombose_medicatie | MBH_300_WDS_trombose_medicatie_MA | MBH_300_WDS_trombose_medicatie_VV |
| 6.17 | Redundante frequentie |
MBH_300_redundantefrequentie | MBH_300_redundantefrequentie_MA | MBH_300_redundantefrequentie_VV |
1.2.6 Scenarioset 7
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 7.1 | Alle ingrediënten |
MBH_300_magistraalalleingredienten | MBH_300_magistraalalleingredienten_MA | MBH_300_magistraalalleingredienten_VV |
| 7.2 | Actief ingrediënt |
MBH_300_magistraalactieveingredient | MBH_300_magistraalactieveingredient_MA | MBH_300_magistraalactieveingredient_VV |
| 7.3 | 90 miljoen nummer |
MBH_300_magistraal90miljoennr | MBH_300_magistraal90miljoennr_MA | MBH_300_magistraal90miljoennr_VV |
| 7.4 | Vrije tekst product |
MBH_300_vrijetekstproduct | MBH_300_vrijetekstproduct_MA | MBH_300_vrijetekstproduct_VV |
1.2.7 Scenarioset 8
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 8.1 | Verstrekkingsverzoek onder andermans medicatieafspraak |
MBH_300_VVandermansMA | MBH_300_VVandermansMA_MA | MBH_300_VVandermansMA_VV |
| 8.2 | Stoppen andermans medicatieafspraak |
MBH_300_stakenandermansMA | MBH_300_stakenandermansMA_MA2 | |
| 8.3 | Onderbreken andermans medicatieafspraak |
MBH_300_stakenandermansMA | MBH_300_stakenandermansMA_MA2 | |
| 8.4 | Wijzigen andermans medicatieafspraak |
MBH_300_wijzigenandermansMA | MBH_300_wijzigenandermansMA_MA_techstaken MBH_300_wijzigenandermansMA_MA2 |
1.2.8 Scenarioset 9
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 9.1a | Logistieke verbruiksperiode |
MBH_300_logistiekeverbruiksperiode_start_eind | MBH_300_logistiekeverbruiksperiode_start_eind_MA | MBH_300_logistiekeverbruiksperiode_start_eind_VV |
| 9.1b | Logistieke verbruiksperiode |
MBH_300_distributievorm_GDS | MBH_300_distributievorm_GDS_MA | MBH_300_distributievorm_GDS_VV |
| 9.1c | Logistieke verbruiksperiode |
MBH_300_logistiekeverbruiksperiode_duur_dagen | MBH_300_logistiekeverbruiksperiode_duur_dagen_MA | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV |
| 9.2 | Herhalingen |
MBH_300_herhalingen | MBH_300_herhalingen_MA | MBH_300_herhalingen_VV |
| 9.3 | Afleverlocatie |
MBH_300_afleverlocatie | MBH_300_afleverlocatie_MA | MBH_300_afleverlocatie_VV |
| 9.4 | Financiële indicatiecode |
MBH_300_financiele_indicatiecode | MBH_300_financiele_indicatiecode_MA | MBH_300_financiele_indicatiecode_VV |
| 9.5a | Geannuleerd indicator |
MBH_300_geannuleerd_indicator | MBH_300_geannuleerd_indicator_MA | MBH_300_geannuleerd_indicator_VV |
| 9.5b | Geannuleerd indicator |
MBH_300_geannuleerd_indicator | MBH_300_geannuleerd_indicator_MA | MBH_300_geannuleerd_indicator_VV |
1.2.9 Scenarioset 10
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 10.1 | HPK geneesmiddel |
MBH_300_HPKvoorschrijven | MBH_300_HPKvoorschrijven_MA | MBH_300_HPKvoorschrijven_VV |
| 10.2 | ZI-nr geneesmiddel |
MBH_300_ZINRvoorschrijven | MBH_300_ZINRvoorschrijven_MA | MBH_300_ZINRvoorschrijven_VV |
1.2.10 Scenarioset 11
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 11.1 | Medicatievoorschrift met een medicatieafspraak verwijzend naar extern doseerschema |
MBH_300_wdsmtd1 | MBH_300_wdsmtd1_MA | MBH_300_wdsmtd1_VV |
1.2.11 Scenarioset 13
| Scenario | Beschrijving | MBH id | MA id | VV id |
| 13.1 | Relatie naar patiëntcontact en zorgepisode |
MBH_300_contactepisode | MBH_300_contactepisode_MA | MBH_300_contactepisode_VV |
1.3 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en einddatum
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Scenario 1.1 - MBH_300_start_eind
| Medicatieafspraak MBH_300_start_eind_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:20 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 5 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 5 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_start_eind_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:20 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 5 stuks | ||
| Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.4 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en duur (weken)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Scenario 1.2a - MBH_300_start_duur
| Medicatieafspraak MBH_300_start_duur_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:30 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 3 weken | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 3 weken | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_start_duur_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:30 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.4.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.5 TEST Scenarioset 1 Gebruiksperiode ingangsdatum en duur (dagen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Scenario 1.2b - MBH_300_start_duur2
| Medicatieafspraak MBH_300_start_duur2_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:30 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_start_duur2_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:30 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 28 stuks | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.5.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.6 TEST Scenarioset 1 Chronische medicatie
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Scenario 1.3 - MBH_300_chronisch
| Medicatieafspraak MBH_300_chronisch_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:32 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_chronisch_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:32 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.7 TEST Scenarioset 1 Extra VV onder bestaande MA
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Scenario 1.4 - MBH_300_chronisch
| Medicatieafspraak MBH_300_chronisch_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T - 20 dagen om 11:32 uur | ||
| Gebruiksperiode | Vanaf T - 20 dagen | ||
| Ingangsdatum | T - 20 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_chronisch_VV_extraVVbestaandeMA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:35 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.8 TEST Scenarioset 1 MA met eenheid 'dosis/stuks'
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Scenario 1.5 - MBH_300_dosis_stuks
| Medicatieafspraak MBH_300_dosis_stuks_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:35 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 29 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 29 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per dag 1 dosis | ||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_dosis_stuks_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dosis_stuks_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:35 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 1 stuk | ||
| Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.9 TEST Scenarioset 1 MA met onzekerheidscriterium
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Scenario 1.6 - MBH_300_start_criterium
| Medicatieafspraak MBH_300_start_criterium_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_criterium_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:20 uur | ||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten) | ||
| Ingangsdatum | T + 1 dag | ||
| Gebruiksduur | 3 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag | ||
| MBH identificatie | MBH_300_start_criterium (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_start_criterium_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_criterium_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:20 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 30 gram | ||
| Geneesmiddel - primaire code | CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_start_criterium_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_criterium (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.9.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.10 TEST Scenarioset 2 Aanvullende Instructie
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Scenario 2.1 - MBH_300_aanvullendeinstructie
| Medicatieafspraak MBH_300_aanvullendeinstructie_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 12 maanden | ||
| Ingangsdatum | T | ||
| Einddatum | T + 12 maanden | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_aanvullendeinstructie_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinstructie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.10.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.11 TEST Scenarioset 2 Toelichting
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Scenario 2.2 - MBH_300_toelichting
| Medicatieafspraak MBH_300_toelichting_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:02 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Toelichting | In overleg met specialist | ||
| MBH identificatie | MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_toelichting_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:02 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
| RelatieMedicatieafspraak | MBH_300_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.12 TEST Scenarioset 2 Reden van voorschrijven
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Scenario 2.3 - MBH_300_redenvanvoorschrijven
| Medicatieafspraak MBH_300_redenvanvoorschrijven_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:05 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 27 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenVanVoorschrijven | Reumatoide artritis (code = 'L88.01' in codeSystem 'ICPC-1'): Reumatoide artritis | ||
| Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 5 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 5 stuks | ||
| MBH identificatie | MBH_300_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_redenvanvoorschrijven_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redenvanvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 20 stuks | ||
| Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.12.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.13 TEST Scenarioset 2 Aanvullende informatie en wensen
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Scenario 2.4 - MBH_300_aanvullendeinformatiewensen
| Medicatieafspraak MBH_300_aanvullendeinformatiewensen_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:06 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 10 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 10 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) | ||
| AanvullendeInformatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_aanvullendeinformatiewensen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:06 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| AanvullendeWensen | Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051') | ||
| RelatieMedicatieafspraak | MBH_300_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.13.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.14 TEST Scenarioset 2 Toedieningsweg
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Scenario 2.5 - MBH_300_Toedieningsweg
| Medicatieafspraak MBH_300_Toedieningsweg_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 7 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 druppel, In het rechter oog, oculair | ||
| Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
| Doseerinstructie | 2 maal per dag 1 druppel | ||
| AanvullendeInformatie | Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
| MBH identificatie | MBH_300_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_Toedieningsweg_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_Toedieningsweg_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:15 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 1 ml | ||
| Geneesmiddel - primaire code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.14.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.15 TEST Scenarioset 3 (initieren scenario) Stoppen
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Scenario 3.1a - MBH_300_stoppen
| Medicatieafspraak MBH_300_stoppen_MA_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 280 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 280 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_stoppen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.15.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.16 TEST Scenarioset 3 Stoppen
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.16.1 Scenario 3.1b - MBH_300_stoppen
| Medicatieafspraak MBH_300_stoppen_MA_staken | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 18:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 1 dag | ||
| Ingangsdatum | T | ||
| Einddatum | T + 1 dag | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenWijzigenOfStaken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.16.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
1.17 TEST Scenarioset 3 (initieren scenario) Wijzigen MA (verhoging)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.17.1 Scenario 3.2a - MBH_300_wijzigen_verhoging
| Medicatieafspraak MBH_300_wijzigen_verhoging_MA_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:02 uur | ||
| Gebruiksperiode | Vanaf T om 09:00 uur | ||
| Ingangsdatum | T om 09:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_wijzigen_verhoging_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:02 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.17.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.18 TEST Scenarioset 3 Wijzigen (verhoging)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.18.1 Scenario 3.2b - MBH_300_wijzigen_verhoging
| Medicatieafspraak MBH_300_wijzigen_verhoging_MA_wijzigingmetVV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:02 uur | ||
| Gebruiksperiode | Vanaf T om 09:00 uur | ||
| Ingangsdatum | T om 09:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenWijzigenOfStaken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieafspraak MBH_300_wijzigen_verhoging_MA_techstaken | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:02 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T om 09:00 uur | ||
| Ingangsdatum | T | ||
| Einddatum | T om 09:00 uur | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_wijzigen_verhoging_VV_extra | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_VV_extra (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:02 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.19 TEST Scenarioset 3 (initieren scenario) Wijzigen (verlaging)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.19.1 Scenario 3.3a - MBH_300_wijzigen_verlaging
| Medicatieafspraak MBH_300_wijzigen_verlaging_MA_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:05 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 27 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 2 maal per week 1 stuk | ||
| MBH identificatie | MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_wijzigen_verlaging_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 20 stuks | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.19.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.20 TEST Scenarioset 3 Wijzigen (verlaging)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.20.1 Scenario 3.3b - MBH_300_wijzigen_verlaging
| Medicatieafspraak MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:10 uur | ||
| Gebruiksperiode | Vanaf T + 6 dagen, tot en met T + 14 dagen | ||
| Ingangsdatum | T + 6 dagen | ||
| Einddatum | T + 14 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenWijzigenOfStaken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieafspraak MBH_300_wijzigen_verlaging_MA_techstaken | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:10 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 6 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 6 dagen | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.20.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
1.21 TEST Scenarioset 3 (initieren scenario) Onderbreken
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.21.1 Scenario 3.4a - MBH_300_onderbreken
| Medicatieafspraak MBH_300_onderbreken_MA_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:06 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 10 dagen om 15:00 uur | ||
| Ingangsdatum | T | ||
| Einddatum | T + 10 dagen om 15:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_onderbreken_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:06 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.21.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.22 TEST Scenarioset 3 Onderbreken
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.22.1 Scenario 3.4b - MBH_300_onderbreken
| Medicatieafspraak MBH_300_onderbreken_MA_onderbreken | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 18:12 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T om 15:00 uur | ||
| Ingangsdatum | T | ||
| Einddatum | T om 15:00 uur | ||
| MedicatieafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenWijzigenOfStaken | verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.22.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
1.23 TEST Scenarioset 3 TA wijzigen (onveranderde MA)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.23.1 Scenario 3.5 - MBH_300_TAwijzigen
| Medicatieafspraak MBH_300_TAwijzigen_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:30 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_TAwijzigen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:30 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 28 stuks | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.23.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.24 TEST Scenarioset 3 (initieren scenario) annuleren
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.24.1 Scenario 3.6a - MBH_300_annuleren
| Medicatieafspraak MBH_300_annuleren_MA_starten | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 7 dagen, tot en met T + 49 dagen om 00:00 uur | ||
| Ingangsdatum | T + 7 dagen | ||
| Einddatum | T + 49 dagen om 00:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| MBH identificatie | MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_annuleren_VV_starten | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_VV_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 14:10 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 42 stuks | ||
| Geneesmiddel - primaire code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.24.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.25 TEST Scenarioset 3 annuleren
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.25.1 Scenario 3.6b - MBH_300_annuleren
| Medicatieafspraak MBH_300_annuleren_MA_geannuleerd | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_MA_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 4 dagen, tot en met T + 4 dagen om 00:00 uur | ||
| Ingangsdatum | T + 4 dagen | ||
| Einddatum | T + 4 dagen om 00:00 uur | ||
| MedicatieafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| RedenWijzigenOfStaken | Overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Neuropsychiatrische effecten | ||
| Geneesmiddel - primaire code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.25.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
1.26 TEST Scenarioset 3 (initieren scenario) VolgendeBehandelaar
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.26.1 Scenario 3.7a - MBH_300_VolgendeBehandelaar
| Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Start1 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 12:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 100 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 100 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VolgendeBehandelaar_VV_Start1 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VolgendeBehandelaar_VV_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 12:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 100 stuks | ||
| Geneesmiddel - primaire code | APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.26.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.27 TEST Scenarioset 3 (stoppen scenario) VolgendeBehandelaar
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.27.1 Scenario 3.7b - MBH_300_VolgendeBehandelaar
| Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Stop1 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VolgendeBehandelaar_MA_Stop1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:00 uur | ||
| Gebruiksperiode | Vanaf T - 49 dagen, tot en met T | ||
| Ingangsdatum | T - 49 dagen | ||
| Einddatum | T | ||
| MedicatieafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | ||
| RedenWijzigenOfStaken | opname in instelling (code = '305335007' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.27.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener JAN_VAN_HARTEN | |||||
| ZorgverlenerIdentificatienummer | 000002222 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Jan van Harten | ||||
| Specialisme | Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534321 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART | ||||
| Zorgaanbieder ZIEKENHUIS_HET_GELE_HART | |||||
| ZorgaanbiederIdentificatienummer | 00004444 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Ziekenhuis het Gele Hart | ||||
| Adresgegevens | Werkadres: Groenestraat 1 1200AA Hartstad | ||||
| OrganisatieType | Ziekenhuis (code = 'V4' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | ||||
1.28 TEST Scenarioset 3 VolgendeBehandelaar
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.28.1 Scenario 3.7c - MBH_300_VolgendeBehandelaar
| Medicatieafspraak MBH_300_VolgendeBehandelaar_MA_Start2 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VolgendeBehandelaar_MA_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:00 uur | ||
| Gebruiksperiode | Vanaf T + 4 dagen, tot en met T + 51 dagen | ||
| Ingangsdatum | T + 4 dagen | ||
| Einddatum | T + 51 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | ||
| VolgendeBehandelaar | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR | ||
| RedenWijzigenOfStaken | hervatten van beleid van vorige voorschrijver (code = '112261000146100' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_VolgendeBehandelaar_MA_Start1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VolgendeBehandelaar_VV_Start2 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VolgendeBehandelaar_VV_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 13:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | ||
| TeVerstrekkenHoeveelheid | 47 stuks | ||
| Geneesmiddel - primaire code | APIXABAN TABLET 5MG (code = '105678' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | APIXABAN TABLET 5MG (code = '141992' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VolgendeBehandelaar_MA_Start2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VolgendeBehandelaar (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.28.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener JAN_VAN_HARTEN | |||||
| ZorgverlenerIdentificatienummer | 000002222 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Jan van Harten | ||||
| Specialisme | Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534321 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART | ||||
| Zorgverlener BERTINE_VAN_DOORN_VOLGENDEBEHANDELAAR | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR | ||||
| Zorgaanbieder ZIEKENHUIS_HET_GELE_HART | |||||
| ZorgaanbiederIdentificatienummer | 00004444 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Ziekenhuis het Gele Hart | ||||
| Adresgegevens | Werkadres: Groenestraat 1 1200AA Hartstad | ||||
| OrganisatieType | Ziekenhuis (code = 'V4' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS_VOLGENDEBEHANDELAAR | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.29 TEST Scenarioset 3 Stoppen parallelle TA (onveranderde MA)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.29.1 Scenario 3.8 - MBH_300_stoppen_parallele_TA
| Medicatieafspraak MBH_300_stoppen_parallele_TA_MA_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:05 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 28 dagen | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's ochtends en Bij pijn 1 stuk 's avonds, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 stuk 's ochtends en Bij pijn 1 stuk 's avonds | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_stoppen_parallele_TA_VV_start | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_VV_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 09:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | ||
| TeVerstrekkenHoeveelheid | 28 stuks | ||
| Geneesmiddel - primaire code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.29.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener JAN_VAN_HARTEN | |||||
| ZorgverlenerIdentificatienummer | 000002222 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Jan van Harten | ||||
| Specialisme | Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534321 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART | ||||
| Zorgaanbieder ZIEKENHUIS_HET_GELE_HART | |||||
| ZorgaanbiederIdentificatienummer | 00004444 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Ziekenhuis het Gele Hart | ||||
| Adresgegevens | Werkadres: Groenestraat 1 1200AA Hartstad | ||||
| OrganisatieType | Ziekenhuis (code = 'V4' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.30 TEST Scenarioset 4 Lengte Gewicht
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | E. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Doppen | |||
| Identificatienummer | 999900511 [BSN] | |||
| Geboortedatum | 24 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.30.1 Scenario 4.1a - MBH_300_VOS_Lengte_Gewicht
| Medicatieafspraak MBH_300_VOS_Lengte_Gewicht_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 10:00 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 2 weken | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 2 weken | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VOS_Lengte_Gewicht_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lengte_Gewicht_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 10:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 14 stuks | ||
| Geneesmiddel - primaire code | RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.30.2 Lichaamslengte
| Lichaamslengte | ||
| Gegevenselement | Waarde | |
| LengteWaarde | 164 cm | |
| LengteDatumTijd | T - 12 dagen om 13:14 uur | |
1.30.3 Lichaamsgewicht
| Lichaamsgewicht | ||
| Gegevenselement | Waarde | |
| GewichtWaarde | 102 kg | |
| GewichtDatumTijd | T - 12 dagen om 13:20 uur | |
1.30.4 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
| Lichaamslengte | |||||
| LengteWaarde | 164 cm | ||||
| LengteDatumTijd | T - 12 dagen om 13:14 uur | ||||
| Lichaamsgewicht | |||||
| GewichtWaarde | 102 kg | ||||
| GewichtDatumTijd | T - 12 dagen om 13:20 uur | ||||
1.31 TEST Scenarioset 4 Lengte gewicht persistent
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | E. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Doppen | |||
| Identificatienummer | 999900511 [BSN] | |||
| Geboortedatum | 24 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.31.1 Scenario 4.1b - MBH_300_VOS_Lengte_Gewicht
| Medicatieafspraak MBH_300_VOS_Lengte_Gewicht_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 10:00 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 2 weken | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 2 weken | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VOS_Lengte_Gewicht_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lengte_Gewicht_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 10:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 14 stuks | ||
| Geneesmiddel - primaire code | RIVAROXABAN TABLET 15MG (code = '100145' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 15MG (code = '138355' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VOS_Lengte_Gewicht_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VOS_Lengte_Gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.31.2 Lichaamslengte
| Lichaamslengte | ||
| Gegevenselement | Waarde | |
| Identificatienummer | test-id-lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1) | |
| LengteWaarde | 164 cm | |
| LengteDatumTijd | T om 07:05 uur | |
1.31.3 Lichaamsgewicht
| Lichaamsgewicht | ||
| Gegevenselement | Waarde | |
| Identificatienummer | test-id-gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1) | |
| GewichtWaarde | 98 kg | |
| GewichtDatumTijd | T om 07:05 uur | |
1.31.4 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
| Lichaamslengte | |||||
| Identificatienummer | test-id-lengte (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23023.1) | ||||
| LengteWaarde | 164 cm | ||||
| LengteDatumTijd | T om 07:05 uur | ||||
| Lichaamsgewicht | |||||
| Identificatienummer | test-id-gewicht (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.23028.1) | ||||
| GewichtWaarde | 98 kg | ||||
| GewichtDatumTijd | T om 07:05 uur | ||||
1.32 TEST Scenarioset 4 Nierfunctie NHG
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | E. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Doppen | |||
| Identificatienummer | 999900511 [BSN] | |||
| Geboortedatum | 24 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.32.1 Scenario 4.2a - MBH_300_VOS_Lab
| Medicatieafspraak MBH_300_VOS_Lab_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 07:05 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VOS_Lab_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lab_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 07:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.32.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.33 TEST Scenarioset 4 Nierfunctie Loinc zonder panel
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | E. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Doppen | |||
| Identificatienummer | 999900511 [BSN] | |||
| Geboortedatum | 24 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.33.1 Scenario 4.2b - MBH_300_VOS_Lab
| Medicatieafspraak MBH_300_VOS_Lab_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 07:05 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VOS_Lab_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VOS_Lab_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 07:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VOS_Lab_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VOS_Lab (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.34 TEST Scenarioset 6 Variabele frequentie
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.34.1 Scenario 6.1 - MBH_300_variabelefrequentie
| Medicatieafspraak MBH_300_variabelefrequentie_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 16 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 à 2 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_variabelefrequentie_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.34.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.35 TEST Scenarioset 6 Interval
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.35.1 Scenario 6.2 - MBH_300_interval
| Medicatieafspraak MBH_300_interval_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:04 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | ||
| MBH identificatie | MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_interval_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_interval_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:04 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.35.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.36 TEST Scenarioset 6 Variabele hoeveelheid
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.36.1 Scenario 6.3 - MBH_300_variabelehoeveelheid
| Medicatieafspraak MBH_300_variabelehoeveelheid_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:10 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| MBH identificatie | MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_variabelehoeveelheid_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:10 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 100 stuks | ||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.36.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.37 TEST Scenarioset 6 Zonder keerdosis
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.37.1 Scenario 6.4 - MBH_300_zonderkeerdosis
| Medicatieafspraak MBH_300_zonderkeerdosis_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:12 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 3 maal per dag | ||
| MBH identificatie | MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_zonderkeerdosis_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonderkeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:12 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 100 gram | ||
| Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.37.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.38 TEST Scenarioset 6 Bijzondere keerdosis
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.38.1 Scenario 6.5 - MBH_300_bijzonderekeerdosis
| Medicatieafspraak MBH_300_bijzonderekeerdosis_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 0.5 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 2 maal per dag 0.5 stuk | ||
| MBH identificatie | MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_bijzonderekeerdosis_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_bijzonderekeerdosis_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:15 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.38.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.39 TEST Scenarioset 6 Variabele hoeveelheid 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.39.1 Scenario 6.6 - MBH_300_variabelehoeveelheid2
| Medicatieafspraak MBH_300_variabelehoeveelheid2_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:18 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | ||
| Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| MBH identificatie | MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_variabelehoeveelheid2_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:18 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 450 ml | ||
| Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.39.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.40 TEST Scenarioset 6 Tijdstippen flexibel
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.40.1 Scenario 6.7a - MBH_300_tijdstippen_flexibel
| Medicatieafspraak MBH_300_tijdstippen_flexibel_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:24 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 14 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
| MBH identificatie | MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_tijdstippen_flexibel_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:24 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 45 stuks | ||
| Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.40.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.41 TEST Scenarioset 6 Tijdstippen niet flexibel
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.41.1 Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel
| Medicatieafspraak MBH_300_tijdstippen_niet_flexibel_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 7 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) | ||
| MBH identificatie | MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_tijdstippen_niet_flexibel_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 09:15 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 24 stuks | ||
| Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.41.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.42 TEST Scenarioset 6 Weekdagen
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.42.1 Scenario 6.8 - MBH_300_weekdagen
| Medicatieafspraak MBH_300_weekdagen_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:25 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 70 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | op maandag, woensdag en vrijdag | ||
| MBH identificatie | MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_weekdagen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_weekdagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:25 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.42.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.43 TEST Scenarioset 6 Dagdeel
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.43.1 Scenario 6.9 - MBH_300_dagdeel
| Medicatieafspraak MBH_300_dagdeel_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:27 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 stuk 's avonds | ||
| MBH identificatie | MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_dagdeel_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dagdeel_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:27 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.43.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.44 TEST Scenarioset 6 Cyclisch schema
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.44.1 Scenario 6.10 - MBH_300_cyclischschema
| Medicatieafspraak MBH_300_cyclischschema_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:33 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||
| HerhaalperiodeCyclischSchema | 28 dagen | ||
| MBH identificatie | MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_cyclischschema_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_cyclischschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:33 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 126 stuks | ||
| Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.44.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.45 TEST Scenarioset 6 Afbouwschema
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.45.1 Scenario 6.11 - MBH_300_afbouwschema
| Medicatieafspraak MBH_300_afbouwschema_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:40 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 41 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| MBH identificatie | MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_afbouwschema_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afbouwschema_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:40 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 90 gram | ||
| Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.45.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.46 TEST Scenarioset 6 Variabele hoeveelheid en maximum
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.46.1 Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum
| Medicatieafspraak MBH_300_variabelehoeveelheidenmaximum_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:45 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 21 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
| MBH identificatie | MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_variabelehoeveelheidenmaximum_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:45 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 120 stuks | ||
| Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.46.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.47 TEST Scenarioset 6 Toedieningssnelheid
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.47.1 Scenario 6.13 - MBH_300_toedieningssnelheid
| Medicatieafspraak MBH_300_toedieningssnelheid_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:47 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 8 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | toedieningssnelheid: 0.2 à 0.5 ml/h, parenteraal | ||
| Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | toedieningssnelheid: 0.2 à 0.5 ml/h | ||
| MBH identificatie | MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_toedieningssnelheid_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningssnelheid_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:47 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 100 ml | ||
| Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.47.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.48 TEST Scenarioset 6 Toedieningsduur
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.48.1 Scenario 6.14 - MBH_300_toedieningsduur
| Medicatieafspraak MBH_300_toedieningsduur_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:49 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk gedurende 16 uur, transdermaal | ||
| Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| MBH identificatie | MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_toedieningsduur_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningsduur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:49 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.48.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.49 TEST Scenarioset 6 Zo nodig
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.49.1 Scenario 6.15 - MBH_300_zonodig
| Medicatieafspraak MBH_300_zonodig_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:57 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 27 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Zo nodig 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_zonodig_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonodig_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:57 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 14 stuks | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.49.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.50 TEST Scenarioset 6 Trombosedienst
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.50.1 Scenario 6.16 - MBH_300_WDS_trombose_medicatie
| Medicatieafspraak MBH_300_WDS_trombose_medicatie_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_WDS_trombose_medicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:15 uur | ||
| Gebruiksperiode | Vanaf T, gedurende 2 dagen | ||
| Ingangsdatum | T | ||
| Gebruiksduur | 2 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | FYTOMENADION TABLET 1MG (code = '106720' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FYTOMENADION TABLET 1MG (code = '142697' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 5 stuks 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 5 stuks 's avonds | ||
| MBH identificatie | MBH_300_WDS_trombose_medicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_WDS_trombose_medicatie_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_WDS_trombose_medicatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:15 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 10 stuks | ||
| Geneesmiddel - primaire code | FYTOMENADION TABLET 1MG (code = '106720' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FYTOMENADION TABLET 1MG (code = '142697' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_WDS_trombose_medicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_WDS_trombose_medicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.50.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.51 TEST Scenarioset 6 redundante frequentie
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.51.1 Scenario 6.17 - MBH_300_redundantefrequentie
| Medicatieafspraak MBH_300_redundantefrequentie_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redundantefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:00 uur | ||
| Gebruiksperiode | Vanaf T om 09:00 uur, gedurende 14 dagen | ||
| Ingangsdatum | T om 09:00 uur | ||
| Gebruiksduur | 14 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag om 10:00 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag om 10:00 1 stuk | ||
| MBH identificatie | MBH_300_redundantefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_redundantefrequentie_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redundantefrequentie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 09:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 14 stuks | ||
| Geneesmiddel - primaire code | PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_redundantefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redundantefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.51.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.52 TEST Scenarioset 7 Alle ingrediënten
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.52.1 Scenario 7.1 - MBH_300_magistraalalleingredienten
| Medicatieafspraak MBH_300_magistraalalleingredienten_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T om 12:00 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 31 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | Zo nodig, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | Zo nodig | |||
| MBH identificatie | MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_magistraalalleingredienten_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| VerstrekkingsverzoekDatumTijd | T om 12:00 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| TeVerstrekkenHoeveelheid | 50 ml | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| BeoogdVerstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| RelatieMedicatieafspraak | MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.52.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.53 TEST Scenarioset 7 Actief ingrediënt
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.53.1 Scenario 7.2 - MBH_300_magistraalactieveingredient
| Medicatieafspraak MBH_300_magistraalactieveingredient_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T om 12:05 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | |||
| Ingangsdatum | T + 1 dag | |||
| Einddatum | T + 70 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| MBH identificatie | MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_magistraalactieveingredient_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| VerstrekkingsverzoekDatumTijd | T om 12:05 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| TeVerstrekkenHoeveelheid | 75 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| BeoogdVerstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| RelatieMedicatieafspraak | MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.53.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.54 TEST Scenarioset 7 90 miljoen nummer
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.54.1 Scenario 7.3 - MBH_300_magistraal90miljoennr
| Medicatieafspraak MBH_300_magistraal90miljoennr_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T om 12:08 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| MBH identificatie | MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Verstrekkingsverzoek MBH_300_magistraal90miljoennr_VV | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| VerstrekkingsverzoekDatumTijd | T om 12:08 uur | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| TeVerstrekkenHoeveelheid | 100 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| BeoogdVerstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| RelatieMedicatieafspraak | MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.54.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.55 TEST Scenarioset 7 vrije tekst product
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.55.1 Scenario 7.4 - MBH_300_vrijetekstproduct
| Medicatieafspraak MBH_300_vrijetekstproduct_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 14:52 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag, gedurende 12 weken | ||
| Ingangsdatum | T - 1 dag | ||
| Gebruiksduur | 12 weken | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per 3 weken 1 stuk, Intraveneus | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per 3 weken 1 stuk | ||
| MBH identificatie | MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_vrijetekstproduct_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 14:52 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 4 stuks | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.55.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.56 TEST Scenarioset 8 VV andermans MA
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.56.1 Scenario 8.1 - MBH_300_VVandermansMA
| Medicatieafspraak MBH_300_VVandermansMA_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T - 14 dagen om 09:00 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 6 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Einddatum | T + 6 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | ||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| KopieIndicator | Ja | ||
| MBH identificatie | MBH_300_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_VVandermansMA_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_VVandermansMA_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 09:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 6 stuks | ||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_VVandermansMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_VVandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.56.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
1.57 TEST Scenarioset 8 Staken andermans MA
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.57.1 Scenario 8.2 - MBH_300_stakenandermansMA
| Medicatieafspraak MBH_300_stakenandermansMA_MA2 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T | ||
| Ingangsdatum | T - 5 dagen | ||
| Einddatum | T | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| RedenWijzigenOfStaken | geen indicatie voor medicamenteuze behandeling (code = '183966005' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.57.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.58 TEST Scenarioset 8 Onderbreken andermans MA
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.58.1 Scenario 8.3 - MBH_300_stakenandermansMA
| Medicatieafspraak MBH_300_stakenandermansMA_MA2 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stakenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T | ||
| Ingangsdatum | T - 5 dagen | ||
| Einddatum | T | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| RedenWijzigenOfStaken | geen indicatie voor medicamenteuze behandeling (code = '183966005' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stakenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stakenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.58.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.59 TEST Scenarioset 8 Wijzigen andermans MA
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.59.1 Scenario 8.4 - MBH_300_wijzigenandermansMA
| Medicatieafspraak MBH_300_wijzigenandermansMA_MA_techstaken | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigenandermansMA_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:10 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 1 dag | ||
| Ingangsdatum | T - 7 dagen | ||
| Einddatum | T - 1 dag | ||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 2 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieafspraak MBH_300_wijzigenandermansMA_MA2 | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigenandermansMA_MA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 09:10 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| RedenWijzigenOfStaken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigenandermansMA_MA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigenandermansMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.59.2 Bouwstenen
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.60 TEST Scenarioset 9 Verbruiksperiode start/eind
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.60.1 Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind
| Medicatieafspraak MBH_300_logistiekeverbruiksperiode_start_eind_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 12 maanden | ||
| Ingangsdatum | T | ||
| Einddatum | T + 12 maanden | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_start_eind_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Verbruiksperiode | Vanaf T, tot en met T + 12 maanden | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_logistiekeverbruiksperiode_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.60.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.61 TEST Scenarioset 9 Verbruiksperiode einddatum
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.61.1 Scenario 9.1b - MBH_300_distributievorm_GDS
| Medicatieafspraak MBH_300_distributievorm_GDS_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_distributievorm_GDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:01 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 200 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 200 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_distributievorm_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_distributievorm_GDS_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_distributievorm_GDS_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:01 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Verbruiksperiode | tot en met T + 200 dagen | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_distributievorm_GDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_distributievorm_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.61.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.62 TEST Scenarioset 9 Verbruiksperiode duur (dagen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.62.1 Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen
| Medicatieafspraak MBH_300_logistiekeverbruiksperiode_duur_dagen_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:02 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 150 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_logistiekeverbruiksperiode_duur_dagen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:02 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| Verbruiksperiode | gedurende 50 dagen | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_logistiekeverbruiksperiode_duur_dagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.62.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.63 TEST Scenarioset 9 Herhalingen
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.63.1 Scenario 9.2 - MBH_300_herhalingen
| Medicatieafspraak MBH_300_herhalingen_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:05 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_herhalingen_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| AantalHerhalingen | 5 | ||
| Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_herhalingen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.63.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.64 TEST Scenarioset 9 Afleverlocatie
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.64.1 Scenario 9.3 - MBH_300_afleverlocatie
| Medicatieafspraak MBH_300_afleverlocatie_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:07 uur | ||
| Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 10 dagen | ||
| Ingangsdatum | T + 1 dag | ||
| Einddatum | T + 10 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_afleverlocatie_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afleverlocatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:07 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | ||
| RelatieMedicatieafspraak | MBH_300_afleverlocatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.64.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.65 TEST Scenarioset 9 Financiele indicatiecode
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.65.1 Scenario 9.4 - MBH_300_financiele_indicatiecode
| Medicatieafspraak MBH_300_financiele_indicatiecode_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 11:35 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 13 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 13 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 4 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 4 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_financiele_indicatiecode_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_financiele_indicatiecode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 11:35 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | ||
| TeVerstrekkenHoeveelheid | 56 stuks | ||
| Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| FinanciëleIndicatiecode | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): B2 | ||
| RelatieMedicatieafspraak | MBH_300_financiele_indicatiecode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.65.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener BERTINE_VAN_DOORN | |||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Bertine van Doorn | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.66 TEST Scenarioset 9 geannuleerd indicator start
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.66.1 Scenario 9.5a - MBH_300_geannuleerd_indicator
| Medicatieafspraak MBH_300_geannuleerd_indicator_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:00 uur | ||
| Gebruiksperiode | Vanaf T om 13:00 uur, tot en met T + 180 dagen om 13:00 uur | ||
| Ingangsdatum | T om 13:00 uur | ||
| Einddatum | T + 180 dagen om 13:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_geannuleerd_indicator_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_geannuleerd_indicator_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 13:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.66.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.67 TEST Scenarioset 9 geannuleerd indicator annulering
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.67.1 Scenario 9.5b - MBH_300_geannuleerd_indicator
| Medicatieafspraak MBH_300_geannuleerd_indicator_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:00 uur | ||
| Gebruiksperiode | Vanaf T om 13:00 uur, tot en met T + 180 dagen om 13:00 uur | ||
| Ingangsdatum | T om 13:00 uur | ||
| Einddatum | T + 180 dagen om 13:00 uur | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_geannuleerd_indicator_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_geannuleerd_indicator_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 13:00 uur | ||
| GeannuleerdIndicator | Ja | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 180 stuks | ||
| Geneesmiddel - primaire code | FINASTERIDE TABLET 5MG (code = '34975' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FINASTERIDE TABLET 5MG (code = '87912' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_geannuleerd_indicator_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_geannuleerd_indicator (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.67.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1634534000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.68 TEST Scenarioset 10 HPK
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.68.1 Scenario 10.1 - MBH_300_HPKvoorschrijven
| Medicatieafspraak MBH_300_HPKvoorschrijven_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 150 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_HPKvoorschrijven_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 13:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 150 stuks | ||
| Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.68.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.69 TEST Scenarioset 10 ZI-nummer
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.69.1 Scenario 10.2 - MBH_300_ZINRvoorschrijven
| Medicatieafspraak MBH_300_ZINRvoorschrijven_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 13:05 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 150 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_ZINRvoorschrijven_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 13:05 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 150 stuks | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.69.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.70 TEST Scenarioset 11 extern doseerschema
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Pherai | |||
| Identificatienummer | 999900870 [BSN] | |||
| Geboortedatum | 1 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.70.1 Scenario 11.1 - MBH_300_wdsmtd1
| Medicatieafspraak MBH_300_wdsmtd1_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:00 uur | ||
| Gebruiksperiode | Vanaf T - 20 dagen | ||
| Ingangsdatum | T - 20 dagen | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Volgens schema trombosedienst, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | ||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_wdsmtd1_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wdsmtd1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.70.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||
1.71 TEST Scenarioset 13.1 relatie contact episode
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | H. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hoek | |||
| Identificatienummer | 999900638 [BSN] | |||
| Geboortedatum | 5 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.71.1 Scenario 13.1 - MBH_300_contactepisode
| Medicatieafspraak MBH_300_contactepisode_MA | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RegistratieDatumTijd | T om 08:00 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Voorschrijver | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 2 stuks | ||
| RelatieContact | |||
| Identificatienummer | MBH_300_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709) | ||
| RelatieZorgepisode | |||
| Identificatienummer | MBH_300_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200) | ||
| MBH identificatie | MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Verstrekkingsverzoek MBH_300_contactepisode_VV | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_contactepisode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| VerstrekkingsverzoekDatumTijd | T om 08:00 uur | ||
| Auteur | |||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | ||
| TeVerstrekkenHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| BeoogdVerstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| RelatieMedicatieafspraak | MBH_300_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.71.2 Bouwstenen
| Bouwstenen | |||||
| Gegevenselement | Waarde | ||||
| Zorgverlener PETER_VAN_PULVER | |||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | ||||
| Naamgegevens | Peter van Pulver | ||||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||||
| Contactgegevens | |||||
| Telefoonnummers | |||||
| Telefoonnummer | 1645645000 | ||||
| NummerSoort | Zakelijk telefoonnummer (code = 'WP' in codeSystem 'Address Use') | ||||
| Zorgaanbieder | |||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | ||||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||||